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Spermatogonial stem cells (SSC) exist on the basement membrane of the 
seminiferous tubules in the testis throughout a male animalʼs life. These cells 
self-renew to maintain a stem cell population while producing daughter cells 
that differentiate into sperm. Because of their relatively undistinguishable 
morphology, very little was known about them until testis xenografting and 
spermatogonial stem cell transplantation (SSCT) were developed. Both 
technologies are promising tools to preserve male genetic information as well 
as to study the characteristics of SSC. In this dissertation, I investigate testis 
xenografting and SSCT in cats and dogs, which are important animal models 
for biomedical research.  
 First, I examine the effect of donor age on spermatogenesis in feline 
xenografts and the ability of xenograft-derived sperm to support embryo 
development. In addition, I compare the outcomes of xenografting using testis 
tissue from two additional species of carnivore, dogs and ferrets. My studies 
indicate that the optimal donor age was just prior to onset of puberty and 
xenograft sperm had poor fertility compared to control sperm, necessitating 
further investigation. Furthermore, the comparative study demonstrates 
differences in the ability of testicular tissue from different species of carnivore 
 to establish spermatogenesis following testicular xenografting. Second, I 
describe my development of all three major steps of SSCT in the cat and dog 
including depleting endogenous male germ cells in recipients, isolating male 
germ cells from donors and injecting the isolated germ cells. My studies 
provide a foundation to perform SSCT in the cat, and I was successful at 
performing SSCT in the dog. Finally, I examine multiple steps to develop 
transgenesis in dogs, which will enhance their utility as genetic models. This 
study includes 1) methodology for the accurate staging of dog blastocysts, 2) 
attempted derivation of canine embryonic stem cells (cESC), 3) manipulation 
of blastocysts, and 4) transfer of canine embryos. Our results demonstrate that 
canine transgenesis mediated via cESC and/or SSCT are technically feasible.  
 These studies examine the potential of stem cell-based technologies in 
the preservation of male genetic information and biomedical research. In 
addition, my work provides a foundation to achieve transgenesis in the dog. 
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CHAPTER 1 
Introduction and Literature Review 
 2 
Spermatogenesis is a complex process involving hormonal regulation of, and 
communication between, various somatic cells and germ cells, to achieve its 
ultimate goal of producing haploid male gametes. Although a male animal 
doesnʼt produce sperm until the animal undergoes puberty and becomes 
sexually mature, spermatogonial stem cells (SSC), the stem cells of the male 
germ line, reside and proliferate in the testes beginning soon after the birth of 
the animal. Although, these stem cells were identified several decades ago, 
very little has been discovered about SSC. Their largely unremarkable 
morphological characteristics have hindered research. Above all, the absence 
of a single assay to characterize the cells was the greatest obstacle for this 
field. However, two novel technologies were introduced within the last two 
decades, spermatogonial stem cell transplantation in 1994 and testis 
xenografting in 2002, and these have played critical roles in accelerating SSC 
research. Both techniques allow us to remove male germline stem cells from 
an original animal and transfer them to host animals without losing the stem 
cell nature of the transplanted cells. In this chapter, I intend to review how 
male germ cells develop from early embryos and what events are involved in 
sperm production. I shall then review the properties of spermatogonial stem 
cells, and the technologies based upon them. Because my research has been 
focused on the cat and dog, I shall close with a review of the potential of these 
species as biomedical research models. 
 
Male germ cell development 
1. Fetal germ cell development  
 Mammalian germ cells are induced to form at the posterior region of the 
epiblast, at the junction of the extra-embryonic ectoderm, epiblast, primitive 
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streak, and allantois (Figure 1.1.a) (Hogan 2002). Among the many cells in the 
area, only certain cells will develop to become primordial germ cells (PGC). At 
embryonic day 6-6.5 in rodents, the precursors of PGC express BMP4 and 
BMP8b (Figure 1.1.a) (Lawson, Dunn et al. 1999; Ying, Liu et al. 2000). 
Around embryonic day 7, this cluster of cells emerges from the posterior 
primitive streak, and a few cells in the center of the cluster expressing both 
fragilis and stella, become committed to the germ cell fate (Figure 1.1.b) 
(Saitou, Barton et al. 2002). Mammalian PGC migrate directly into the 
endoderm from the posterior region of the primitive streak (Figure 1.1.c). 
Although the cells exit the hindgut on day 9, PGC are seen migrating into the 
genital ridges during the following day. By embryonic day 11.5, the PGC enter 
the developing gonads (Anderson, Copeland et al. 2000; Molyneaux, Stallock 
et al. 2001). Although PGC express germline-specific genes (Yabuta, 
Kurimoto et al. 2006), they are still pluripotent and are capable of producing 
differentiated cell types representing all three germ layers (Seydoux and Braun 
2006). During their migration to the genital ridges, PGCs proliferate from 10-
100 cells to 2500-5000 cells by day 12. In females, PGCs form oocytes, which 
stop dividing mitotically and enter meiosis, whereas in males the cells become 
gonocytes in the sex cords (Goossens and Tournaye 2006).  
 Because PGC still retain pluripotency and can form teratomas in vivo 
(Noguchi and Stevens 1982; Regenass, Friedrich et al. 1982) and pluripotent 
stem cells in vitro (Matsui, Zsebo et al. 1992; Resnick, Bixler et al. 1992), 
gonocytes can be considered to be the first stem cells that are committed to 
the male germ cell lineage. In rodents, these gonocytes become arrested in 
the G0/G1 phase of the cell cycle after a few days of proliferation (Vergouwen, 
S.G. et al. 1991). Shortly after birth, the gonocytes are released  
 4 
 
Figure 1.1. Model for the development of mammalian primordial 
germ cells. a) BMP signals (blue) from extra-embryonic ectoderm 
induce neighboring epiblast cells (open circles) to become precursors of 
PGC and extra-embryonic mesoderm. These cells move (black arrow) 
toward the posterior epiblast during gastrulation. b) The cells emerge 
from the posterior primitive streak on embryo day 7. A small cluster of 
cells in the center, expressing both fragilis (green) and stella (red), will 
become PGCs. c) Once PGCs are specified, they migrate to the future 
gonad (dashed arrow). Reprinted with permission from Macmillan 
Publishers Ltd: Nature (418, pp.282), copyright (2002). 
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from arrest and become SSC on the basement membranes of the 
seminiferous tubules (Bellve, Cavicchia et al. 1977; Vergouwen, S.G. et al. 
1991). However, it was reported that there are heterogeneous populations of 
these cells in the neonatal testes including a small population of cells that 
become stem cells (de Rooij 1998) and a significant number of cells that 
eventually degenerate (Wang, Nakane et al. 1998). Based on their distinct 
morphological characteristics, Orwig et al. (Orwig, Ryu et al. 2002) identified 
the two subpopulations of gonocytes, pseudopod and round, from rat neonatal 
testes and showed that pseudopod cells become stem cells whereas round 
cells undergo apoptosis. Apoptosis is involved in all stages of male germ cell 
development and its role in balancing survival and death signals is critical to 
prevent spermatogenetic dysfunction (Jahnukainen, Chrysis et al. 2004; 
Russell, Chiarini-Garcia et al. 2002). Therefore, apoptotic activity of round 
gonocytes, which may represent the cells that failed to migrate to the 
basement membrane of the seminiferous cords, might be critical to establish 
normal spermatogenic development in the early testis.  
 
2. Spermatogenesis 
 Spermatogenesis is the process in which spermatogonia produce the 
mature male gametes, spermatozoa, within the seminiferous tubules. This 
process includes a series of mitotic divisions of spermatogonia, two meiotic 
divisions of spermatocytes, extensive morphological transformation of the 
spermatids, and the release of the maturing spermatozoa into the lumen of the 
tubules. In this section, each phase of germ cell development will be reviewed. 
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2.1. Mitotic phase of spermatogenic cells 
 Once gonocytes migrate from the center of the seminiferous cords to 
the basement membrane of the cords, they transform into spermatogonial 
stem cells (SSC) within postnatal day 6 in the mouse (McLean, Friel et al. 
2003). During the proliferative phase, spermatogonial stem cells undergo 
mitotic divisions to produce both new stem cells and daughter cells that are 
committed to differentiation into spermatozoa. The most primitive 
spermatogonia are called ʻtype A spermatogoniaʼ and have a minimum level of 
heterochromatin in the nucleus. With successive increases in the level of 
heterochromatin, the type A spermatogonia become intermediate 
spermatogonia (In), which in turn become type B spermatogonia, which  
display significant heterochromatin in the nucleus. The type A spermatogonia 
consist of subtypes of cells, types A-single (As), A-paired (Apr), A-aligned from 
4 to 16 cells (Aal), and A1, A2, A3 and A4 (de Rooij and Russell 2000). As cells 
are considered to be the true spermatogonial stem cells (SSC) which will 
divide into either two As cells or a pair of Apr. Apr cells divide into chains of Aal 
cells, but they are still connected through intercellular bridges (Figure 1.2) 
(Weber and Russell 1987).  
Figure 1.2. The division and proliferation of undifferentiated 
spermatogonial cells. SSC: spermatogonial stem cell, As: type 
A-single spermatogonia, Apr: A-paired spermatogonia, Aal: A-
aligned spermatogonia. 
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As, Apr, and Aal are considered to be undifferentiated spermatogonia, and they 
share similar phenotypes and likely also share molecular characteristics (de 
Rooij 2001; de Rooij and Russell 2000). A recent study showed that Apr and 
Aal spermatogonia can also resume self-renewal in the condition of loss of 
actual stem cells (Figure 1.3) (Nakagawa, Nabeshima et al. 2007). Aal cells 
progress to become A1 cells without a mitotic division. A1 cells then divide and 
differentiate into A2, A3, A4, In and B spermatogonia. It is challenging to 
distinguish between the undifferentiated spermatogonia by biochemical or 
molecular characteristics. However, it has been shown that in mice these cells 
are distinguishable from differentiating spermatogonia, such as A 1-4, In and B 
spermatogonia, based on differential expression of several cell surface 
markers including c-kit (Schrans-Stassen, van de Kant et al. 1999), β1/α6-
integrin (Shinohara, Avarbock et al. 1999) and Thy-1 (Kubota, Avarbock et al. 
2004). The undifferentiated spermatogonia do not express c-kit but β1/α6-
integrin and Thy-1 whereas the differentiated spermatogonia have the 
opposite expression pattern. In mice, this differential expression of cell surface 
markers can be used to investigate the different properties between 
undifferentiated and differentiated spermatogonia. Additional markers for 
murine male germ cells at different stages of development are shown in Table 
1.1.  
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Figure 1.3. Model of the spermatogonial stem cell compartment. A. 
During a normal cycle of spermatogenesis, stem cell potential is not 
limited to the cells that actually self-renew in the stem cell niche (actual 
stem cells) but also some cells that do not normally self-renew might 
possess this potential (potential stem cells). Both of these 
compartments are included in the undifferentiated spermatogonia entity. 
B. Upon loss of the actual stem cells, the potential stem cells would 
switch their mode from proliferation to self-renewal, generating a pool of 
new actual stem cells (indicated by a red arrow). According to 
Nakagawa et al., 2007. (Nakagawa, Nabeshima et al. 2007)  
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Markers PGCs gonocytes SSC Differentiated spermatogonia 
Fragilis + + + ? 
C-Kit + + - + 
DAZL -/+ + + + 
Stella - + + + 
Vasa - + + + 
Miwi/Mili + + + + 
Mil1 -/+ + + + 
Mil2 - + + + 
TNAP + - - - 
SSEA-1 + - - - 
Oct-3/4 + + + - 
α6/β1 
integrin - + + - 
Thy-1 ? + + - 
Plzf + + + - 
GCNA1 - + + + 
RET ? ? + - 
GFR α1 ? ? + - 
NCAM ? + + ? 
Table 1.1. Description of differential expression during male germ 
cell development in mice 
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2.2. Meiotic and post-meiotic phase of spermatogenic cells 
 Mature mammalian gametes must be haploid. To achieve this reduction 
in chromosomes, the germ cells undergo meiosis (Figure 1.4). With the onset 
of puberty, spermatogonia begin meiosis and give rise to the preleptotene 
spermatocytes. During prophase, the sizes and the nuclei of cells will 
progressively increase as the preleptotene spermatocytes progress into 
leptotene, zygotene, pachytene, and diplotene primary spermatocytes (Figure 
1.5) (Russell and Frank 1978). These primary spermatocytes undergo meiotic 
DNA replication and recombination of homologous chromosomes. The 
diplotene spermatocytes undergo metaphase, anaphase, and telophase to 
complete the first meiotic division, or meiosis I.  The cells now become 
secondary spermatocytes that will undergo the second meiotic division, or 
meiosis II, resulting in haploid spermatids (Russell, Ettlin et al. 1990). These 
spermatids are initially small round cells with a pale nucleus and a moderate 
amount of cytoplasm. However, during the third phase of spermatogenesis, or 
spermiogenesis, the round spermatids undergo extreme transformations into 
the complex form of spermatozoa including condensation of the nucleus, 
formation of the acrosome and flagellum, elimination of cytoplasm, and the 
arrangement of its mitochondria into a helix (Setchell 1978). This process is 
undergone without cell division and results in the reduction of the volume of 
the spermatid by approximately 25 % of its original size. 
 
2.3. Microenvironment of testis 
 All adult stem cells can maintain a ʻsteady stateʼ – generating one 
replacement stem cell and one differentiated progeny cell with no limit. Their 
specialized functions depend upon their neighboring differentiated cells by  
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Figure 1.4. Meiosis of spermatogenic cells.  Chromosomes are 
recombined and genetic material is halved in each sperm as a result 
of the two meiotic divisions.  
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Figure 1.5. Schematic diagram of a pair of homologous chromosomes 
during prophase. In leptotene, the chromosomes begin to condense into 
long strands but remain unpaired. The homologous chromosomes become 
paired in synaptonemal complexes during zygotene. In pachytene stage, 
the chromosomes are fully lined up and genetic recombination takes place, 
by randomly exchanging segments of genetic information between 
nonsister chromatids (chromatids 1/2 vs. 3/4) at ʻrecombination nodulesʼ. In 
diplotene, the synaptonemal complex dissipates, allowing the 
chromosomes to separate, except at chiasmata, where the crossing-over 
occurred. 
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signals and intercellular interactions. Consequently, location is as significant in 
the characterization of stem cells as are the special patterns of gene 
expression of the cells. The particular microenvironments that might control 
stem cells are called ʻnichesʼ. A niche can be defined as a subset of cells and 
extra-cellular substrates that can indefinitely house one or more stem cells and 
control their self-renewal and progeny production in vivo (Spradling, 
Drummond-Barbosa et al. 2001). Spermatogonial stem cells are located on the 
basal membrane of the seminiferous tubules, surrounded by Sertoli cells, the 
somatic supporting cells for this lineage (Figure 1.6). These cells produce 
various growth factors that regulate SSC self-renewal as well as differentiation. 
Glial cell line derived neurotrophic factor (GDNF) and fibroblast growth factor 2 
(FGF-2) support self-renewal while activin A, bone morphogenic protein 4 
(BMP 4) and stem cell factor stimulate differentiation of SSCs (Buageaw, 
Sukhwani et al. 2005; Goriely, McVean et al. 2005; Kubota, Avarbock et al. 
2004; Mauduit, Hamamah et al. 1999; Meng, Lindahl et al. 2000; Naughton, 
Jain et al. 2006). It has been shown that SSCs are not randomly distributed on 
the basement membrane of the tubule but are preferentially located in the area  
close to the interstitial tissue (Chiarini-Garcia, Hornick et al. 2001; Yoshida, 
Sukeno et al. 2007). A recent study by Shinohara et al. (Kanatsu-Shinohara, 
Takehashi et al. 2008) showed that β1-integrin, an extracellular matrix 
component on SSC and Sertoli cells, plays an important role not just in 
migration of SSC into the niche but also in differentiation of SSC.  
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Figure 1.6. The spermatogonial stem cell niche. SSC 
(green) are located on the basal membrane of the 
seminiferous tubule in close contact with Sertoli cells (gray). 
Sertoli cells produce GDNF and FGF2 for regulating self-
renewal of SSCs. To the lumen side of the SSC, the blood-
testis barrier (BTB) is formed by tight juctions between 
neighboring Sertoli cells. The SSC niches can be found in 
those regions of the tubules that border interstitial tissue. β1-
integrin plays an important role in homing of the SSCs and 
may be involved in regulation of SSC differentiation. 
Reprinted from Cell Stem Cell, 3(5), de Rooij, 467-468, 
Copyright (2008) with permission from Elsevier.   
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Applications of male germline stem cells 
1. Testis xenografting 
 Testis xenografting is typically performed by putting 1-2 mm3 sized 
pieces of testicular tissue into immunodeficient mice. Spermatogonial stem 
cells remaining in the testis tissue can survive in the recipient and eventually 
they produce sperm, supported by local testosterone produced under the 
regulation of the recipient mouseʼs endocrine system. This technique is a 
promising tool to study spermatogenesis as well as preserve male genetic 
information. Currently, sperm cryopreservation is the most common method to 
preserve male reproductive materials; however, it is not always possible to 
collect the male gamete, such as in the case of pre-pubertal males. Therefore, 
testis xenografting becomes very valuable for males that might die before ever 
producing sperm or who might need chemotherapy that would cause loss of 
their SSC. Even though testis xenografting is a straightforward technique, 
there are several considerations to perform it. First, prior to the current studies, 
it was unclear whether testis tissue from donors of different ages could support 
spermatogenesis as xenografts. Secondly, because only testis tissue is 
grafted, the sperm cannot undergo further maturation in the epididymis, which 
is essential for them to fertilize. Therefore, sperm produced by xenografts 
must be injected directly into oocytes, through the process of intracytoplasmic 
sperm injection (ICSI), to produce offspring. Although testis xenografting has 
been performed with various donor species including rodents (Schlatt, 
Honaramooz et al. 2003), farm animals (Rathi, Honaramooz et al. 2005; Rathi, 
Honaramooz et al. 2006; Zeng, Avelar et al. 2006), companion animals (Kim, 
Selvaraj et al. 2007; Snedaker, Honaramooz et al. 2004), primates 
(Honaramooz, Li et al. 2004; Rathi, Zeng et al. 2008) and humans (Geens, De 
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Block et al. 2006; Schlatt, Honaramooz et al. 2005), only a few studies have 
used sperm generated from xenografts to produce either offspring [mouse 
(Ohta and Wakayama 2005; Schlatt, Honaramooz et al. 2003)] or embryos 
[rhesus monkey (Honaramooz, Li et al. 2004) and pig (Honaramooz, Cui et al. 
2008)]. There is no doubt that spermatogonial stem cells are maintained and 
supported to produced advanced germ cells in xenograft; however, further 
investigation is required to verify whether the sperm produced by the 
xenografts are normal in being able to fertilize oocytes and lead to normal 
embryo development. Furthermore, once xenografts are implanted in the 
recipients, there is only a limited timeframe to retrieve the sperm. To expand 
the potential of this technique, it should be studied whether frozen-thawed 
sperm collected from grafts could fertilize and contribute to normal embryo 
development. Alternatively, it may be possible to extend the time window by 
freezing testis tissue until it is needed (Jahnukainen, Ehmcke et al. 2007).  
 
2. Spermatogonial stem cell transplantation 
 Spermatogonial stem cell transplantation (SSCT) was first reported in 
the mouse (Brinster and Zimmermann 1994), and it remains a powerful tool to 
verify the actual functional ability of putative SSC to produce sperm. In this 
technique, either populations of spermatogonia, or mixed germ cell 
populations containing spermatogonia, are placed within the lumens of the 
seminiferous tubules of a recipient. Placement is performed either by 
retrograde injection through the efferent ducts (rodents (Ogawa, Arechaga et 
al. 1997)), or via retrograde injection into the rete testis (large animal models 
(Honaramooz, Behboodi et al. 2003; Honaramooz, Megee et al. 2002)). 
Xenogeneic SSCT, in which the donor and recipient are different species, has 
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been performed using several species as donor and mice as recipients 
(Clouthier, Avarbock et al. 1996; Ogawa, Dobrinski et al. 1999). However, if 
the phylogenetic distance between the donor and recipient is too wide, the 
donor spermatogonia can colonize but spermatogenesis will not occur 
(Dobrinski, Avarbock et al. 1999; Kim, Selvaraj et al. 2006; Nagano, McCarrey 
et al. 2001). Therefore, different recipient species must be established for 
different donor species.  
 A recipient animal should have its endogenous germ cells depleted, so 
that the introduced cells will have improved access to the basal compartment 
of seminiferous tubules and so that there is a higher relative yield of donor-
derived sperm (Brinster, Ryu et al. 2003). Two techniques have been widely 
used to reduce or deplete endogenous male germ cells as recipient 
preparation for SSCT: focal irradiation (Honaramooz, Behboodi et al. 2003; 
Izadyar, den Ouden et al. 2003; Schlatt, Foppiani et al. 2002) and 
chemotherapeutic drugs (Brinster, Ryu et al. 2003; Ogawa, Arechaga et al. 
1997). SSCT has been used for various species such as pig (Honaramooz, 
Megee et al. 2002), monkey (Schlatt, Foppiani et al. 2002), goat 
(Honaramooz, Behboodi et al. 2003), cow (Herrid, Vignarajan et al. 2006) and 
dog (Kim, Turner et al. 2008). Transplantation of SSC from wild-type mice into 
the testes of mice having genetic infertility showed successful restoration of 
spermatogenesis in the recipient testes (Rilianawati, Speed et al. 2003). In 
addition, SSCT can be used not only to restore male fertility but also to 
generate transgenic animals. Various research groups showed that 
transduced SSC can generate sperm carrying a transgene after 
transplantation, and these can eventually produce transgenic mice (Nagano, 
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Brinster et al. 2001), rats (Ryu, Orwig et al. 2006), and transgenic goat 
embryos (Honaramooz, Megee et al. 2008).  
 
3. Pluripotent stem cells derived from male germline stem cells  
 During normal development, SSC are restricted to differentiate into a 
single cell type, spermatozoa; however, several studies showed that SSC can 
give rise to embryonic stem cell-like cells in certain culture conditions, 
demonstrating the potential pluripotency of SSC.  As reviewed in the previous 
section, Kanatsu-Shinohara et al. cultured SSC (Kanatsu-Shinohara, Ogonuki 
et al. 2003) in the presence of several growth factors including GDNF, which 
might be the most important factor in the regulation of self-renewal and 
proliferation of SSC (Braydich-Stolle, Nolan et al. 2005; Kubota, Avarbock et 
al. 2004; Meng, Lindahl et al. 2000). However, they also observed other kinds 
of colonies that were different from germline stem cells but similar to 
embryonic stem (ES) cell colonies. Further investigation showed that these 
colonies could be maintained in standard ES cell medium and had the same 
properties as ES cells, including expression of ES cell markers, and formation 
of teratomas, embryonic bodies and chimeras (Kanatsu-Shinohara, Inoue et 
al. 2004). Different groups have derived pluripotent stem cells from 
spermatogonial stem cells in modified culture conditions (Guan, Nayernia et al. 
2006; Seandel, James et al. 2007). Interestingly, it does not seem to require a 
very specific approach to transform SSC into ES-like cells. This transition can 
occur on different feeder cells or even without feeder layers, substituted by 
leukemia inhibitory factor (LIF). In addition, the culture medium can also be 
varied while still supporting the transformation, as the groups of Kanatsu-
Shinohara et al. (Kanatsu-Shinohara, Inoue et al. 2004) and Seandel et al. 
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(Seandel, James et al. 2007) used a stem cell medium whereas Guan et al. 
(Guan, Nayernia et al. 2006) used DMEM, although all three groups used 
GDNF. The ES-like cells derived from SSC were able to differentiate into 
specific cell lineages such as cardiomyocytes (Guan, Wagner et al. 2007) and 
endothelial cells (Baba, Heike et al. 2007). The earlier studies of the 
transformation were obtained in mice; however, recent studies showed that 
adult human germline stem cells could generate pluripotent stem cells as well 
(Conrad, Renninger et al. 2008; Kossack, Meneses et al. 2008). Therefore, the 
plasticity of male germline stem cells allows one to derive ES-like cells. The 
implications of this might well prove to be of importance for biomedical 
research and future clinical applications. 
 
The domestic cat and dog as research models  
 Laboratory rodents have been widely and successfully used to 
understand mammalian biology. Generating transgenic mice is usually the 
ultimate step in functional characterization of mouse and human genomic loci. 
However, this approach is not without its limitations. Because there are 
significant differences in genetic and physiological profiles between humans 
and mice, development of appropriate mouse models for a large number of 
critical human diseases has been difficult. In addition, the mouse is severely 
limited as a behavioral model because of its limited repertoire of social 
interactions. Therefore, developing other mammalian models such as the dog 
and the cat, which have a more similar genome, behavior, and physiology to 
humans, is highly desirable for human medicine and veterinary research. 
 The recently completed sequencing of the dog genome 
(http://www.genome.gov/17515860) enables the dog to become a plausible 
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genetic model. Over 360 naturally-occurring canine genetic diseases have 
been shown to have counterparts in humans, including various forms of 
cancer (Lingaas, Comstock et al. 2003), blindness (Acland, Aguirre et al. 
2005), and orthopedic defects (Athanasiou, Agarwal et al. 1995). Moreover, 
several diseases have been shown to involve the same gene in both species, 
such as muscular dystrophy and bleeding disorders (Ostrander and Wayne 
2005). More than 400 different breeds have been generated by humans and 
many of these breeds originate from only a few founders and/or have 
undergone population bottlenecks. Therefore, many purebred dogs have 
unique genetic and phenotypic traits including susceptibility to certain genetic 
diseases. Availability of large numbers of different breeds allows researchers 
to use linkage analysis to identify genes responsible for traits and diseases. 
Once the genes involved in canine genetic diseases are identified using this 
approach, transgenic dog models would greatly facilitate our understanding of 
gene function and ultimately, the development of therapies and cures for the 
disease. 
 Like the dog, the cat has served as a research model for decades. 
Nearly 272 hereditary disorders have been found in domestic cats (Murphy 
2006). Many of them result from the establishment of fifty domestic cat breeds 
in a short period of time. Almost a third of the diseases are unique to cats, 
having no counterpart in mice and dogs, which make them unique models for 
those diseases. The cat model has critically contributed in neurological 
research because a large number of characterized feline diseases are 
lysosomal storage diseases which have manifestations as human neurological 
disorders (Crawley, Brooks et al. 1996; Haskins, Casal et al. 2002; Haskins, 
Jezyk et al. 1980; He, Lowrie et al. 2005; Rabinowitz, Sheridan et al. 1991; 
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Wenger, Gasper et al. 1986; Yogalingam, Bielicki et al. 1997). In addition, the 
cat model has great potential for studies of infectious diseases and 
reproductive biology. Feline immunodeficiency virus (FIV) (Kanzaki and 
Looney 2004) and feline infectious peritonitis virus (FIPV) (Pearks Wilkerson, 
Teeling et al. 2004) are the most notable diseases that have counterparts in 
humans--human immunodeficiency virus (HIV) and SARS coronavirus, 
respectively. Because many felid species have very poor sperm quality 
(Pukazhenthi, Wildt et al. 2001), teratospermic felids can be models for human 
male infertility. The feline genome sequencing is at 2x coverage, which is far 
behind the dog genome sequencing project. However, feline geneticists have 
verified the causative mutations on coat color and disease phenotypes 
(Murphy 2006). As the genome sequencing progresses, linkage analyses and 
functional studies to identify the responsible genes for complex diseases will 
be accelerated, which will likely result in greater demand of the cat as a 
research model.  
 Research on both domestic dogs and cats can play significant roles in 
wildlife conservation efforts as well as being applied to human health. About 
21 % of mammals are “threatened” or “endangered,” and the number of 
species so listed continues to grow larger every year 
(http://www.iucn.org/redlist). Since the physiology and pathology of domestic 
dogs and cats resemble greatly those of wild canids and felids, domestic 
carnivores can be excellent models for wildlife conservation applications.  
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Objectives 
 The aims of this dissertation are to optimize the stem cell-based 
reproductive technologies of SSCT and testis xenografting in the cat and dog, 
and to investigate the potential applications of these techniques, with a special 
emphasis on canine transgenesis. To facilitate the development of canine 
transgenesis, this dissertation includes investigations of female reproduction in 
the dog, because increased knowledge is needed in the “downstream” 
technologies of estrous synchronization, and embryo collection, manipulation, 
and transfer.  
 The specific objectives of my research are as follows:   
• To optimize testis xenografting in the cat, first identifying the effect of 
the age of donor tissue, and then characterizing the functional abilities 
of sperm produced by xenografts 
• To compare the success of testis xenografts using donor tissue from 
the ferret and dog 
• To optimize spermatogonial stem cell transplantation in the cat and dog 
• To investigate estrous synchronization in dogs, as well as embryo 
manipulation and transfer  
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CHAPTER 2 
Feline testicular xenografting:  
Effect of donor age on success of spermatogenesis in feline testis xenografts* 
and  
Function of sperm produced in the xenografts‡ 
 
 
 
*Kim, Y., Selvaraj, V., Pukazhenthi, B. and Travis, A. J. 2007. Effect of donor 
age on success of spermatogenesis in feline testis xenografts. Reprod. Fertil. 
Dev. 19(7): 869-876.  
‡Kim, Y., Commizoli, P., Pukazhenthi, B. and Travis, A. J. Function of sperm 
produced in feline testicular xenografts. In preparation 
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Abstract 
 Ectopic xenografting of “donor” feline testicular tissue into a “recipient” 
immunodeficient mouse is a promising tool to preserve the male genome from 
genetically valuable felids. To define parameters under which the technique 
can succeed, we compared the effect of donor age on xenograft 
spermatogenesis among 4 age groups of domestic cats (Felis catus; 8 weeks 
to 15 months). In all cases, fresh tissue was grafted into castrated mice and 
collected 10, 30 and 50 weeks later. The percentage of xenografts recovered 
decreased as donor age increased. Mature testicular sperm were observed in 
xenografts from the 8 and 9-16 week age groups; only a single 7 month-old 
donor produced elongating spermatids, and xenografts from donors > 8 
months old degenerated. Seminal vesicle weight, an indicator of bioactive 
testosterone, was not significantly different among donors aged 8 weeks to 7 
months versus controls, suggesting that xenograft Leydig cells were ultimately 
functional even in the 5–7 month age group. Regardless of donor age, 
production of mature sperm from xenografts was markedly delayed versus 
controls. Comparison of xenografts that produced sperm versus normal 
controls revealed a decrease in tubule cross-sections having post-meiotic 
germ cells. Based on the results of donor age effect, testis tissue from kittens 
younger than 4 mos old was used to study the properties of sperm produced in 
xenografts. We performed intracytoplasmic sperm injection (ICSI) to test their 
ability to contribute to normal embryo development. The cleavage rate of 
xenograft sperm-injected oocytes was 52.6% compared to 66.7% and 75% 
with fresh and frozen sperm-injected oocytes, respectively. None of the 
xenograft sperm-injected oocytes developed above 16 cell-stage, whereas 
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37.7% of control oocytes developed to 16 cell- or blastocyst stages. Together, 
these results indicate that the maximum practical donor age was just prior to 
onset of puberty and that even successful xenografts had abnormalities in 
spermatogenesis. Furthermore, xenograft produced sperm had poor fertility 
compared to control testicular sperm, necessitating further investigation of the 
function of xenograft sperm.  
 
Introduction 
 The loss of genetic diversity due to infertility or the death of rare 
individuals is a critical obstacle to the conservation of endangered species, as 
well as to the maintenance of lines of research animals used to study inherited 
disease. The development of techniques to preserve genetic information from 
individual males has been the focus of much research (Pukazhenthi, Comizzoli 
et al. 2006). Historically, much emphasis has been placed on sperm 
cryopreservation; more recently, however, attention has also turned to other 
cell types within the testis. 
 During early testis development, gonocytes migrate toward the 
periphery of the seminiferous cords and transform into spermatogonia on the 
basement membrane (Bellve, Cavicchia et al. 1977). The term 
“spermatogonia” encompasses both undifferentiated cells, the spermatogonial 
stem cells (SSC), and a differentiating population that will enter meiosis and 
produce sperm (Ravindranath, Dettin et al. 2003). Because they are present 
from neonatal life into adulthood, SSC can be collected from immature males 
as well as adults. For conservation purposes, use of these cells therefore 
provides a potential complement to the cryopreservation of sperm, which can 
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only be recovered from mature individuals. In addition, as stem cells, the SSC 
have the ability to self renew, which terminally differentiated sperm cannot do. 
Recently, two new techniques, spermatogonial stem cell transplantation 
(SSCT) and testis xenografting, have been developed to take advantage of 
these attributes. In SSCT, “donor” male germ cells are transplanted into the 
testis of a “recipient” whose endogenous germ cells have been depleted or are 
absent (Brinster and Zimmermann 1994). It has been shown that the donor 
SSC can colonize and give rise to functional spermatozoa in a number of 
species (mice (Brinster and Avarbock 1994; Ogawa, Dobrinski et al. 2000), 
rats (Ryu, Orwig et al. 2003) and goats (Honaramooz, Behboodi et al. 2003)). 
In these successful cases, the donor and recipient have either been the same 
species or closely-related species, such as the rat and mouse (Franca, Ogawa 
et al. 1998; Shinohara, Kato et al. 2006). Therefore, this technique could be a 
promising tool for restoration of male fertility or for studies of spermatogenesis. 
However, if the taxonomic distance between donor and recipient is great (such 
as rabbit and dog into mouse (Dobrinski, Avarbock et al. 1999)), then 
xenotransplantation of stem cells is typically not successful. This limits the 
broad practical application of this technique until domestic animal models can 
be tested and optimized for suitability as recipients (Kim, Selvaraj et al. 2006). 
 Xenografting of testis tissue is another technique that relies upon the 
attributes of SSC to preserve male genetic information, but which preserves 
the architecture of the donor testis. This technique is performed by 
transplanting mm-sized pieces of testis tissue from a variety of species into 
immunodeficient mice, in which the xenografts can grow and produce sperm of 
the donor species. It has been performed with tissue from various donor 
species, including pigs and goats (Honaramooz, Snedaker et al. 2002), 
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hamster and monkey (Schlatt, Kim et al. 2002), cattle (Oatley, Reeves et al. 
2005; Rathi, Honaramooz et al. 2005), rabbits (Shinohara, Inoue et al. 2002), 
cats (Snedaker, Honaramooz et al. 2004), humans (Schlatt, Honaramooz et al. 
2005), and horses (Rathi, Honaramooz et al. 2006).   
 Interestingly, the nature of xenograft spermatogenesis varies 
tremendously between species, with xenografted tissue showing a decreased 
time to sperm production in the pig (Honaramooz, Snedaker et al. 2002) and 
primate (Honaramooz, Li et al. 2004), no difference in timing of sperm 
production in the bull (Oatley, de Avila et al. 2004; Rathi, Honaramooz et al. 
2005) , and remarkably delayed sperm production in the cat (Snedaker, 
Honaramooz et al. 2004). The factors that contribute to these species-specific 
responses are largely unknown, and could derive from the xenograft germ 
cells or somatic tissues, or from the hormonal interactions between the 
recipient mouse and the xenografts. In addition, differences in the age of the 
donor might also have effects on the ability of xenografts to support 
spermatogenesis. In most species, full spermatogenesis can be observed in 
xenografts from neonatal donors (Honaramooz, Snedaker et al. 2002; Oatley, 
Reeves et al. 2005; Schlatt, Honaramooz et al. 2003; Snedaker, Honaramooz 
et al. 2004), whereas limited attempts with fully adult testicular tissue have not 
supported spermatogenesis (Arregui, Rathi et al. 2008; Geens, De Block et al. 
2006; Rathi, Honaramooz et al. 2006; Schlatt, Honaramooz et al. 2005). 
Beyond this broad division, only two studies have examined the effect of donor 
age on xenograft success. Of these, work done in cattle focused exclusively 
on early pre-pubertal donors (Schmidt, de Avila et al. 2006), and work done on 
stallions primarily investigated the endocrine regulation of xenograft function 
(Rathi, Honaramooz et al. 2006), with age considered only minimally.  
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 For testis xenografting to be a useful tool for the conservation of 
genetically valuable felids, it is imperative that the range of donor ages for 
which the technique will be successful should be established. Therefore, we 
investigated the effect of donor age on the success of spermatogenesis in 
xenografts from domestic cat testis tissue and the function of sperm produced 
from xenografts in embryo development. Our results provide an effective age 
range for donors and describe further the nature of the delay in sperm 
production in felid testis xenografts (which sets the cat apart from other animal 
models studied to date). In addition, this study gives insight into how donor 
age affects testis xenograft success and whether sperm derived from 
xenografts can induce normal embryo development. 
  
Materials and Methods  
Experimental design 
 The first part of this chapter is to verify the effect of donor age in the 
cat testes xenografts. Because of the age range of donor tissue used in a 
previous study (Snedaker, Honaramooz et al. 2004), we concentrated our 
efforts on the use of donors greater than 5 weeks in age. In our preliminary 
experiments, testis xenografts from fully adult donors (older than 1.5 years old) 
uniformly degenerated (data not shown). We therefore narrowed our study to 4 
age groups: 6 - 8 weeks old (weaning-early juvenile), 9 - 16 weeks old (pre-
pubertal), 5 - 7 months old (pubertal) and 8 - 15 months old (young adult). In 
practice, all our donors for the youngest group were 8 weeks in age, refining 
our definition of that group. These age groupings clearly distinguish the pre-
pubertal from pubertal, because it has been shown that the first sperm can be 
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found within testes between the 5 - 7 months (Tsutsui et al., 2004). The 
second section of this chapter describes tests of the function of sperm that are 
produced in xenografts. Testes were collected from kittens younger than 4 
mos old and sperm were harvested from the xenografts collect 39 – 45 weeks 
after xenografting for further analysis. 
 
Reagents 
All reagents were purchased from Sigma (St. Louis, MO), unless 
otherwise noted. Isoflurane (Abbott Laboratories, North Chicago, IL) was used 
for anesthesia and buprenorphine (Reckitt Benckiser Pharmaceuticals Inc., 
Richmond, VA) was used for analgesia in the experimental mice. For 
histology, 100% and 70% ethanol (Pharmco, Brookfield, CT) and hematoxylin 
and eosin (Electron Microscopy Sciences, Fort Washington, CA) were used. 
Dulbecco modified Eagle medium (DMEM) and minimum essential medium 
(MEM) were purchased from Invitrogen (Carlsbad, CA). 
 
Animals and xenografting procedure 
Donor testes from domestic cats (Felis catus, 12 and 11 cats were 
used for the first and the second studies, respectively) were obtained from 
routine castrations at local veterinary hospitals and shelters. All samples were 
stored and transported in sterile saline at 4˚C, and used within 24 h after 
collection. The testes were washed in cold PBS and visible blood was 
removed by blotting. One third of each testis was incubated overnight in 
Bouinʼs fixative for use as a histological control. The remaining portion of each 
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testis was processed for xenografting.  
Briefly, the tunica albuginea and rete testis were removed and the 
testis parenchyma was cut into specimens measuring 1.5 - 2 mm3. These 
were kept in DMEM containing 100 µg/ml streptomycin sulfate and 100 IU/ml 
penicillin on ice until grafting. Four to eight week old ICR/SCID mice for the 
first study (Taconic, Germantown, NY) were used as recipients. However, 
recipient mice were replaced by Ncr/Nude strain (Taconic) due to longer life 
expectancy for the latter strain. Anesthesia was induced and maintained with 
1.5 - 3.5% isoflurane. Castration was performed via a midline abdominal 
approach and an incision was then made on the dorsal midline and 6 -10 
xenografts were placed under the skin (3-5 on each side, approximately 1 cm 
lateral of midline, and evenly spaced between the shoulder to the hips). A 5 
mm length of 6-0 silk (Ethicon, Somerville, NY) was used to mark the site of 
graft placement to facilitate retrieval, and to loosely tether the grafts to prevent 
movement. The dorsal incision was closed with skin staples (Braintree 
Scientific, Inc., Braintree, MA). At the end of surgery, buprenorphine (1 mg/kg) 
was used for analgesia. All experimental protocols were reviewed and 
approved by the Institutional Animal Care and Use Committee of Cornell 
University. Information regarding the number of donors and recipients for the 
first study can be found in Table 2.1. 
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Age group No. of donorsa Donor age 
No. of 
miceb 
No. of 
graftsc  
Total 
graftsd  
8 weeks 2 16  
8 weeks 2 16 49 8 weeks 3 
8 weeks 2 17  
10 weeks 2 16  
14 weeks 2 17 50 9-16 weeks 3 
16 weeks 2 17  
5 months 1 8  
5 months 1 8 36 5-7 months 3 
7 months 2 20  
8 months 2 16  
12 months 2 19 51 8-15 months 3 
15 months 2 16  
 
a: Total number of donors for each age group 
b: Number of recipient mice used per donor  
c: Total number of xenografts per donor 
d: Total number of xenografts placed for each age group 
Table 2.1. Experimental design  
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Analysis of xenografts  
 Based on the findings of Snedaker (Snedaker, Honaramooz et al. 
2004), we evaluated the progress of spermatogenesis at 10, 30 and 50 weeks 
after xenograft placement. At these times, 2 or more xenografts from multiple  
donors were retrieved from recipient mice. The collected xenografts were 
measured in size and fixed in Bouinʼs solution overnight. The fixed xenografts 
were washed out of the Bouinʼs solution into 70% ethanol, and then 
dehydrated in ethanol prior to embedding in paraffin and sectioning at 4 µm 
thickness. After mounting on slides, each section was deparaffinized with 
xylene and hydrated with 100% and 70% ethanol and water, prior to staining 
with hematoxylin and eosin. The sections were scanned under an Eclipse 
TE2000-U microscope (Nikon, Melville, NY) and images were captured using 
a Retiga 1300 color camera (QImaging corporation, Burnaby, BC, Canada) or 
a Spot RT camera (Diagnostic Instruments, Inc., Sterling Heights, MI).  
Xenograft cross-sections were evaluated for the appearance and 
architecture of seminiferous tubules and Leydig cells, and for the presence of 
meiotic cells and progression of germ cell differentiation. Xenografts that 
showed collapsed seminiferous tubules and did not contain germ cells at 
identifiable stages were considered to be degenerated. Because xenografts 
were collected at different time points when different stages of germ cell 
development could be expected, xenograft “success” was defined variably at 
10 weeks if seminiferous tubules contained any evidence of meiosis, at 30 
weeks if pachytene primary spermatocytes were clearly visible, and at 50 
weeks if elongating spermatids were visible. This changing definition of 
success emphasizes the production of later stages of spermatogenesis 
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because the primary goal of this work is to produce elongating spermatids and 
mature sperm to be used for technologies of assisted reproduction. At least 10 
histological sections of each xenograft were examined for the most advanced 
germ cell type in the seminiferous tubule cross-sections, and the percentage 
of tubule cross-sections with each stage of germ cell types was calculated. 
The xenografts that produced sperm were compared against testes from age-
matched controls to determine whether spermatogenesis in xenografts was 
similar to in vivo spermatogenic cell development.  
When all xenografts were retrieved, the seminal vesicles were 
harvested from the recipient mice and weighed as an indicator of bioactive 
testosterone. Data from four retired breeder SCID mice were used to provide a 
control of normal seminal vesicle weight.   
 
Gamete collection and preparation 
Feline ovaries were collected from local veterinary clinics and 
transported in PBS at 4 °C within 6 hrs after ovario-hysterectomy. Grade I 
immature oocytes (with homogeneous dark cytoplasm, surrounded by several 
layers of compacted cumulus cells) were harvested from sliced ovaries and 
then cultured in in vitro maturation (IVM) medium containing MEM with 0.1 mM 
L-Glutamine, 1.0 mM pyruvate, 100 IU/ml penicillin, 100 µg/ml streptomycin, 4 
mg/ml bovine serum albumin (BSA), 1 µg/ml follicular stimulating hormone 
(1.64 IU/ml, NIDDK-ovine FSH-18; National Hormone and Pituitary Program, 
Rockville, MD), 1 µg LH/ml (1.06 IU/ml; NIDDK-oLH-25; National Hormone and 
Pituitary Program), 1 µg/ml estradiol for 30 hrs in 50-µl microdrops (10 
oocytes/microdrop) under equilibrated mineral oil at 38.5 °C in 5% CO2 in air. 
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 Testicular xenografts were harvested at 39 – 45 weeks after 
implantation. All recovered grafts were measured and transported in DMEM 
supplemented with penicillin and streptomycin at the same dose above at 4 °C 
within 24 hrs to the laboratory performing ICSI. Upon arrival, the sperm were 
harvested by mincing the graft tissue in complete Hepes-Ham, which was 
composed of Hepes-Ham F10 medium (Irvine Scientific, Santa Ana, CA) 
supplemented with 1.0 mM pyruvate, 2.0 mM glutamine, 100 IU/ml penicillin, 
100 µg/ml streptomycin and 5% of FBS at room temperature. The sperm 
suspension was collected from the minced tissue and centrifuged at 300 x g 
for 8 min. The sperm pellet was resuspended in 50 µl of 0% glycerol-TEST 
egg yolk solution (Irvine Scientific) in a cryovial and then an equal volume of 
8% glycerol-TEST was added to make a final concentraion of glycerol at 4%. 
The mixture was cooled in a water bath for 2 h and then frozen 1 inch over 
LN2 vapor for 10 min. The frozen sperm were kept in LN2 tank until ICSI 
procedure. Adult cat testes were obtained from local veterinary hospitals to 
collect testicular sperm, which served as controls. 
 
ICSI procedure 
 Frozen sperm were thawed in a water bath at 37ºC and centrifuged at 
300 x g for 8 min.  The pellet was re-suspended for ICSI procedure in the 
complete Hepes-Ham.  Five microliters of thawed xenograft sperm and either 
fresh or frozen control testicular sperm was mixed with an equal volume of 
10% polyvinylpyrrolidone (PVP; Irvine scientific). The two different sperm 
drops were placed separately in the center of a 50 x 9 mm Petri dish and 
surrounded with four 10-µL drops of complete Hepes-Hamʼs containing in vitro 
matured oocytes (previously denuded by gentle pipetting in 0.2% 
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hyaluronidase). The dish was flooded with mineral oil and maintained on the 
heated stage (38.5 °C) of an inverted microscope (Olympus BX41, Olympus 
Corporation, Melville, NY) equipped with micromanipulators (Narishige, 
Sterling, VA), holding and micro-injection pipettes (Humagen Fertility 
Diagnostics, Inc., Charlottesville, VA). A single morphologically normal 
spermatozoon was selected from a sperm drop, aspirated and injected into the 
middle of an oocyte with a visible first polar body. After ICSI, oocytes were 
activated by incubation in complete Hepes-Hamʼs (containing 7% ethanol) for 
5 min at 38.5 ˚C. After extensive rinsing, injected oocytes were cultured in vitro 
in complete Hamʼs without Hepes (38.5 8C, 5% CO2 in air). At 7 days of 
culture, embryos were fixed and stained with Hoechst 33342 to assess 
blastomere numbers.  
 
Statistical analysis 
All data were analyzed using Origin 7.0 Software (OriginLab 
Corporation, Northampton, MA). ANOVA was performed to evaluate potential 
correlations between xenograft success and donor age and the difference in 
xenograft size at different times of collection. In addition, a Studentʼs t-test was 
performed to compare the difference in spermatogenic cell development 
between the xenografts and normal cat testes. Statistical significance was 
considered at p < 0.05. 
 
 
 
 45 
Results 
Histological analysis 
 Table 2.2 shows that the percentage of xenografts recovered from 
recipient mice decreased as donor age increased, and the percentage of the 
xenografts which contained germ cells at different stages of spermatogenesis 
varied with both donor age and the retrieval time points. For the 8 week old 
and 9 - 16 week old donor age groups in our study, we had a percent recovery 
rate very similar to those reported for other species (Rathi, Honaramooz et al. 
2005; Zeng, Avelar et al. 2006).  
 At the 10 week time point, spermatocytes were seen as the most 
advanced germ cell stage in successful xenografts from the 3 youngest donor 
groups: 8 week, 9 –16 week, and 5 – 7 months old (Figure 2.1B, 2.1F, and 
2.1J, respectively). Seminiferous tubules in xenografts collected at this time 
from 8 – 15 month old donors had degenerated (Figure 2.1N). Early elongating 
spermatids were the most advanced germ cells in the xenografts of 9 – 16 
weeks old donors (Figure 2.1G) at 30 weeks after xenografting, whereas 
spermatocytes were the most advanced germ cells in the xenografts from the 
8 week old (Figure 2.1C) and 5 – 7 month old groups (Figure 2.1K) at this time 
point. In the 8 – 15 month old donor group, most of the xenografts retrieved at 
the 30-week time point had degenerated; however, one xenograft was found 
with rare spermatocytes that did not appear to be normal (Figure 2.1O). 
Complete spermatogenesis, defined by the presence of mature testicular 
sperm, was observed in 13.3 % and 16.6 % of the recovered xenografts from 
the 8 week old (Figure 2.1D) and 9 – 16 week old groups (Figure 2.1H), 
respectively, at 50 weeks post procedure. Elongating spermatids were found 
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as the most advanced stage of germ cell development from one 7 month-old 
donor (Figure 2.1L), whereas xenografts from donors 8 months of age or older 
were invariably degenerated at 50 weeks post implantation (Figure 2.1P).  
 
 
 
 
 
 
 
Most advanced germ cell stages in 
xenografts (%)* Age 
group 
Grafts 
Recovered 
(%)^  
Time 
after 
grafting 
(weeks) SG SC RS ES Sperm 
10 87.5 37.5 - - - 
30 73.3 33.3 - - - 
 8 
weeks 
old 
81.6 
50 80.0 80.0 40.0 20.0 13.3 
10 80.0 80.0 - - - 
30 100 100 57.1 28.6 - 
9-16 
weeks 
old 
72.0 
50 100 100 70.8 50.0 16.6 
10 50.0 25.0 - - - 
30 42.8 42.8 - - - 
5-7 
months 
old 
63.8 
50 87.5 50.0 25.0 12.5 - 
10 - - - - - 
30 9.0 9.0# - - - 
8-15 
months 
old 
33.0 
50 - - - - - 
 
^: Total number of xenografts retrieved divided by the total number of grafts 
placed 
*: Total number of xenografts which contained the indicated stage of germ cell 
development divided by the total number of xenografts retrieved at that time 
point, SG: spermatogonia, SC: spermatocytes, RS: round spermatids, ES: 
elongating spermatids, Sperm: spermatozoa  
#: The spermatocytes in this section did not appear to be normal. 
Table 2.2. Effect of donor age on parameters of spermatogenesis in 
feline testis xenografts 
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Figure 2.1. Cross-sections of xenograft seminiferous tubules. 
Panels shown under “0 weeks” are representative of the histological 
appearance of donor tissue at the time of xenografting.  Panel A 
represents an 8 week old donor; panel E a 14 week old donor; panel I 
a 5 month old donor; and panel M a 12 month old donor. Xenografts 
were collected from the different donor age groups [8 weeks (B, C, D), 
9 - 16 weeks (F, G, H), 5 - 7 months (J, K, L) and 8 - 15 months (N, O, 
P)] at 10, 30, and 50 weeks post-procedure. Spermatocytes (arrow 
heads in these panels) were the most advanced cells from the 
xenografts collected at 10 (B, F, J) and 30 weeks (C, K, O) post 
grafting. Elongating spermatids (arrow heads in these panels) were 
the most advanced germ cells from the 9 - 16 week donor xenografts 
collected at 30 weeks (G), and from the 5 - 7 month donor xenografts 
collected at 50 weeks (L) post procedure. Arrowheads in panels D 
and H show spermatozoa as the most advanced germ cells in the 
xenografts collected at 50 weeks for the 8 week and 9 - 16 week 
donor age groups. Xenografts from young adult donors were all 
degenerated at 10 weeks (N) and 50 weeks (P) after xenografting, 
although apparently abnormal spermatocytes were seen rarely from 
one donor at the 30-week time point. Bar = 15 µm except for panels 
A, E, I, M, N and P (100 µm). 
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Evaluation of xenograft testosterone production 
  Seminal vesicle development is highly androgen dependent (Setchell 
1978). Therefore, in the castrated recipients, it is commonly used as a marker 
for xenograft production of bioactive testosterone (Rathi, Honaramooz et al. 
2006; Schlatt, Honaramooz et al. 2003; Schmidt, de Avila et al. 2006). The 
average weight of recipient seminal vesicles varied only slightly among the 3 
youngest donor age groups (174 ± 41.2 mg for 8 week old donors; 157 ± 53.7 
mg for 9 - 16 week old donors; and 215 ± 29.2 mg for 5 - 7 month old donors, 
Figure 2.2), whereas a significant decrease was seen in seminal vesicle 
weight of recipients of the 8 - 15 month old donor tissue (23.5 ± 9.6 mg). When 
compared against the seminal vesicle weights of control SCID mice (294.84 ± 
16.3 mg), only the latter group showed a statistically significant difference (p = 
0.001). Of note, seminal vesicle weights in the recipients of 5 - 7 month old  
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Figure 2.2. Seminal vesicle weight for each donor age group.  Seminal 
vesicles were collected and weighed at 50 weeks post xenografting and 
were compared against control tissue from intact retired breeder SCID 
mice (n = 4). An asterisk (*) indicates a significant difference (p < 0.05) 
between the 8 - 15 month old age group and the control. Data are 
presented as mean ± SEM. 
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donor tissue were similar to those in the younger donor age groups even 
though the xenografts in the 5 - 7 month old donor group were rarely 
successful at the 50 week time point. 
 
Effect of donor age on spermatogenesis in testis xenografts 
 Per collection time point, we pooled the size data from what we defined 
as successful versus unsuccessful xenografts and found a significant 
difference between the two for the 10- and 50-week time points (p = 0.006 and 
0.04, respectively), with successful xenografts being larger than unsuccessful 
xenografts. When data from all three time points were pooled, the size 
difference between successful and unsuccessful xenografts was also 
significant (p < 0.0001). However, when looking at the data as a scatter plot 
(Figure 2.3A and 2.3B), with individual xenografts distinguished for age group 
and outcome, one can see that larger xenograft size at the time of retrieval 
was not entirely predictive of success, nor was small xenograft size entirely 
predictive of failure (Figure 2.3B). Expansion of Leydig cells and seminiferous 
tubules that contained only Sertoli cells contributed to the size of large, but 
unsuccessful, xenografts (data not shown).   
 Even in successful xenografts, there appeared consistently a subset of 
seminiferous tubules that contained no germ cells (Figure 2.4). At the 50-week 
time point in xenografts showing complete spermatogenesis, 20.4 ± 1.6% of 
seminiferous tubule cross-sections contained no germ cells (Figure 2.4A and 
2.5A). Data in Figure 2.5 were calculated in two ways (Groups A and B), and 
those data in group B were compared with a control group (C). Percentages in 
group A were based on the total number of seminiferous tubule cross- 
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Figure 2.3. Scatter plot of xenograft size and outcome.  Xenografts 
were collected from each donor group at three different time points post 
procedure and measured. Panel B is a close-up view of smaller sized 
xenografts (0 – 16 mm3) from panel A, to show that small size did not 
necessarily preclude success. 
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Figure 2.4. Cross-sections of a successful testis xenograft and a 
control testis.  Panel A shows a xenograft at 50 weeks post-
procedure from the 8 week-old donor group.  Note the appearance of 
degenerating tubules (arrowheads) interspersed between tubule 
cross-sections containing meiotic germ cells.  Note also the 
connective tissue capsule, which formed around the xenografts. Panel 
B shows a 12-month-old control. In both panels, the bar represents 
500 µm. 
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sections, including those containing no germ cells. To compare 
spermatogenesis in the xenografts versus that in normal cat testes more 
accurately, we also determined percentages after having factored out the 
empty tubules (Group B). Even with this correction, a significant difference (p < 
0.001) was observed in the pattern of spermatogenesis between tubules in 
xenografts versus normal testis from adult cats (n = 3). The percentages of 
tubules having spermatocytes and elongating spermatids were not significantly 
different, but the percentages containing round spermatids and sperm were 
significantly lower than those of controls (p < 0.001 for both). The percentage 
of tubules containing spermatogonia was also significantly different (p < 
0.001), although the difference between the values was exceedingly small.   
 
Analysis of xenograft sperm and embryo produced with the sperm 
 A total of 120 grafts were recovered out of 168 xenografts placed, at 
time points between 39 and 45 weeks after implantation. Sperm were found in 
22 grafts (18%) and most of them showed morphological abnormalities, mainly 
microcephaly and missing midpieces. Nineteen morphologically normal 
xenograft sperm were retrieved from cryopreservation and injected into in vitro 
matured oocytes. As controls, 15 fresh and 12 frozen testicular sperm were 
also injected into oocytes. 52.6% of oocytes with xenograft sperm were 
cleaved which is not significantly different from the rates of fresh and frozen 
control sperm (66.7% and 75%, respectively). As shown in Figure 2.6, all 
xenograft sperm-injected oocytes arrested at earlier stages than morula, 
whereas frozen testicular sperm-injected ooctyes developed up to blastocyst 
stage (7 morulae and 2 blastocysts) at 7 days post ICSI. 
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Figure 2.5. Percentage of seminiferous tubule cross-sections 
containing different stages of spermatogenic cells. Percentages 
in groups A and B were derived from three xenografts that produced 
morphologically mature sperm at the 50 week time point, and 
percentages in group C were derived from testes of three normal 
cats (9 - 15 months old). The distribution of spermatogenic cells in 
seminiferous tubules was calculated differently for the groups. In 
group A, the number of tubules containing each germ cell type (or 
no germ cells) was divided by the total number of tubule cross-
sections (n = 1777) in the xenografts. Group B is similar to A, but 
the number of tubule cross-sections containing no germ cells was 
excluded from the total (n = 1184). In control group C, the number of 
tubule cross-sections containing each germ cell type was divided by 
the total number of cross-sections assessed (n = 900). Asterisks (*) 
indicate a significant difference (p < 0.05) between Group B and 
Group C. Data are shown as mean ± SEM.  
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Figure 2.6. The embryos generated by ICSI. Panel A shows an early 
blastocyst (200 µm), generated with control testicular sperm, at day 7 in 
culture and panel B shows a xenograft sperm-injected embryo (150 µm) 
arrested at 8 cell-stage at the same day. Blue fluorescence labeled 
indicates DNA in the nuclei. 
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Discussion 
 Across species used in various xenografting studies, the variable of 
donor age has not been intensively studied, although defining the parameters 
under which the technique can be used successfully is a critical requirement 
for moving the technology to practical application, and for providing basic 
scientific understanding of the determinants of xenograft success and failure. 
A major finding of our study was that once meiotic cells appeared consistently 
throughout a donor testis, the ability of that tissue as a xenograft to support 
spermatogenesis declined dramatically.  This was seen in two ways:  for 
donors > 8 months in age, there was complete degeneration of xenografts.  
For donors aged 5 - 7 months, the period when the first sperm are produced 
and spermatogenesis begins in the majority of tubules [(Tsutsui, Kuwabara et 
al. 2004), and data not shown], xenografts typically failed to support full 
spermatogenesis, although they did often support early meiosis up to 
spermatocytes. The findings of degenerating spermatocytes from one donor in 
the 8 - 15 month group, and of elongating spermatids from one donor in the 5 - 
7 month age group, point out the presence of minor individual variations 
between samples. This perhaps represents focal variation in the timing of 
onset of spermatogenesis within a testis.  For example, we have noted 
previously the presence of sperm in epididymides from 5 month-old cats, 
although no histological evidence for complete spermatogenesis was seen in 
the vast majority of testis cross-sections examined from those animals (Kim, 
Selvaraj et al. 2006). Conversely, the one 7-month old donor might have had a 
focal area that lagged behind the spermatogenic development seen in the rest 
of its testis, and the rest of the donors in its age group.  
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 Interestingly, xenografts from the youngest donor group had an initial 
slight acceleration of the onset of meiosis compared to age-matched controls 
(compare Figure 2.1B and 2.1I).  Spermatocytes were observed in 
approximately one-third of the xenografts 10 weeks post-procedure in the 8 
week-old donor group, as opposed to typically appearing at age 5 - 6 months. 
This has been noted by others (Oatley, Reeves et al. 2005; Rathi, 
Honaramooz et al. 2005; Zeng, Avelar et al. 2006) working not only with 
species in which sperm production is accelerated, but also species in which 
sperm production occurs at approximately the same time as in age-matched 
control testes.  The most likely explanation for this early onset of meiosis is 
that the xenograft tissue is suddenly exposed to an adult endocrine profile in 
the recipient mouse, and the germ cells are able to respond (Honaramooz, 
Snedaker et al. 2002; Rathi, Honaramooz et al. 2005; Schlatt, Honaramooz et 
al. 2003). 
 Despite this initial hastening, fully mature sperm were still not 
recovered until after they would have appeared in a normal testis. These 
findings potentially help narrow the underlying cause(s) of species differences 
in time until xenograft sperm production:  regardless of donor species, it 
seems that xenografts are stimulated equally and initially can respond similarly 
when placed into an adult endocrine environment. However, the feline 
xenografts differ in that they do not become competent to support full 
spermatogenesis for some time. This suggests an immaturity of some 
component within the feline testis xenograft. Alternatively, the feline xenografts 
might have been completely mature with regard to their ability to maintain 
response, but a mismatch between donor and recipient regarding the 
endocrine environment resulted in effective hormonal support that was 
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borderline insufficient to maintain spermatogenesis.  Only after a prolonged 
period was a relatively small subset of meiotic cells able to complete their 
differentiation.   
 In the 9 - 16 week donor group, spermatogenesis was initially slightly 
delayed versus age-matched control testis, but xenografts from this group had 
a more normal rate of spermatogenesis, with elongating spermatids seen by 
30 weeks.  It is therefore likely that had our study design included additional 
time points, we might have found mature spermatozoa in some xenografts 
earlier than 50 weeks.  However, our experimental design was derived to 
maximize the chance of finding success, as opposed to finding the earliest 
time of xenograft success.  
 Differences in xenograft success between pre-pubertal and pubertal 
donor testes offer the possibility that inherent differences in the stem cell 
cohorts between these ages might contribute to success or failure in ability to 
support spermatogenesis. However, it is also possible that somatic cell 
components or later stages of germ cell development also factor prominently 
in the effect of donor age. Rathi (Rathi, Honaramooz et al. 2005) suggested 
that meiotic/post-meiotic cells might be less likely to survive the hypoxia 
associated with the procedure. This is logical given the requirements in 
rodents for oxidative metabolism as opposed to glycolysis in post-meiotic germ 
cells (Bajpai, Gupta et al. 1998; Grootegoed, Jansen et al. 1986; Nakamura, 
Okinaga et al. 1986), and could account for the loss of differentiating male 
germ cells seen soon after placement of donor tissue containing meiotic cells. 
Yet, once having been lost, the underlying complement of SSC should 
theoretically still have been the same as in pre-pubertal donors, and therefore 
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should still have been able to recover and repopulate to support 
spermatogenesis over the 50 week period. The failure of the xenografts to do 
so suggests that there were indeed differences in either the stem cell or 
somatic cell components of the testis that arose during puberty, and which 
affected the ability to recover from this initial loss. One potential endocrine-
based rationale might be that once having been “entrained” to a normal feline 
endocrine profile in puberty, the pubertal or young adult feline testis was less 
adaptable to the murine endocrine profile than feline testes that had not yet 
been exposed to an increase in gonadotropins. 
 Unlike what was seen in the 5 - 7 month age group, where the 
xenografts often survived despite being unable to support spermatogenesis, 
xenograft failure in the young adult (8 - 15 month) group was more typically a 
complete failure in which the xenografts did not survive and were not able to 
be retrieved. This type of failure could represent alterations in 
growth/angiogenic factors in testicular somatic cells that led to global hypoxia 
and tissue damage. In addition, complete failure of Leydig cells or of the 
seminiferous epithelium, or some combination thereof, could have occurred. 
 Of practical importance, larger xenografts producing more sperm 
would have benefits in terms of ease of sperm recovery.  Yet for use in 
procedures such as intra-cytoplasmic sperm injection, even low numbers of 
sperm could have significant impacts on genetic diversity within a population. 
In this regard, xenograft size was correlated with, but was certainly not entirely 
predictive of, either success or failure. Even in successful xenografts, many 
tubule cross-sections contained no evidence of germ cells. The finding that 
these cross-sections were not restricted to focal areas but could be found in 
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multiple places within a successful xenograft argues against regional 
microenvironmental factors, such as hypoxia or nutrient starvation on one side 
of a graft as contributing to the failure. Rather, success within a specific region 
of a tubule within a xenograft might depend on the timing of the spermatogenic 
wave within that region. To compare xenograft spermatogenesis more 
accurately versus normal controls, we factored out those cross-sections that 
did not support male germ cell development. Still, the remaining tubule cross-
sections showed differences versus normal testis controls.  In particular, the 
percentage of cross-sections containing stages of post-meiotic germ cells was 
decreased. This finding suggests meiotic arrest within many of the cross-
sections, and these arrested tubules could then degenerate, leading to the 
empty tubules just discussed.  Whether this suggestion of meiotic arrest points 
toward other changes in meiosis that were not detectable histologically is an 
extremely important question.  
 Although testing the quality and function of sperm produced by testis 
xenografts is an essential step, there have been a few reports about 
generating embryos or offspring using xenograft sperm. Honaramooz et al. 
(Honaramooz, Snedaker et al. 2002) demonstrated that sperm produced from 
mouse, pig and goat testicular xenografts can activate mouse oocytes and the 
study of Schlatt et al. (Schlatt, Honaramooz et al. 2003) showed that mouse 
progeny were produced with xenograft-derived sperm via ICSI. In the current 
study, we attempted ICSI with sperm produced from cat testicular xenografts 
to test their quality in supporting embryo development and eventually 
producing kittens. Because about 70% of felid species show teratospermia 
(ejaculation of <40% of morphologically normal sperm), and high numbers of 
domestic cats also are teratospermic (Pukazhenthi, Wildt et al. 2001), we were 
 61 
concerned about possible lack of reproductive fitness of donor animals, which 
would be undetectable at the early age required for successful xenografting. 
This concern proved to be justified, with only 27% of the donors producing 
sperm in the xenografts. Interestingly, using tissue from single donors, multiple 
recipients maintained successful xenografts that produced sperm, providing 
evidence that successful grafts depended more on the fitness of donor tissue 
rather than differences between individual recipients.  
 For our first trial of ICSI, sperm were collected at 48 weeks after 
xenografting. 54.5% of oocytes injected with these sperm cleaved but most of 
them degenerated at the 4-cell stage. In a xenograft, once the sperm mature, 
they will eventually degenerate because of the absence of an outflow tract (i.e. 
there is no epididymis). Therefore, the right timing to collect sperm must be 
optimized, which is not too long after their maturation but long enough so that 
the xenograft can produce enough sperm to be retrieved. Because our earliest 
observation of sperm in cat xenograft was around 39 weeks after implantation, 
we next collected xenografts at the different time points of 40 and 44 weeks to 
minimize degeneration of the sperm. None of the grafts collected at the 40 
week time point produced sperm and the most of germ cells observed were 
spermatocytes (data not shown). A few sperm were found from the xenografts 
collected at 44 weeks. The majority of sperm were microcephalic or had 
missing midpieces and none of the embryos injected with these sperm could 
develop to blastcyst stage. However, even normal cat testicular sperm showed 
a lower success rate of morula-blastocyst development compared to 
ejaculated sperm (Comizzoli, Wildt et al. 2006a), which is not true with other 
species (Van Steirteghem, Nagy et al. 1998; Yanagimachi 2005). Comizzoli et 
al. (Comizzoli, Wildt et al. 2006b) improved ICSI success with cat testicular 
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sperm by co-injecting mature centrosomes collected from ejaculated sperm, 
which seems to be responsible for the first cell division of the embryo. As a 
next step in exploring the function of xenograft-derived sperm, our ICSI 
procedure will include this co-injection of a mature centrosome. 
 Neonatal or juvenile mortality is a significant problem in the captive 
management of threatened/endangered felids.  This is particularly true for 
those species with limited founder populations, in which the breeding success 
of a single individual can have long-term implications for the genetic viability of 
that population. Our findings suggest that the testis xenografting technique 
represents a potentially important complement to current conservation efforts 
by providing a method to preserve the breeding potential of neonatal to pre-
pubertal males.  However, for this to be realized, additional work is needed to 
ensure that sperm produced are functional. 
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CHAPTER 3 
Comparative study of testis xenografting in the dog and the ferret*
 68 
Abstract 
 Testis xenografting is a promising tool to study spermatogenesis and an 
alternative means to preserve the genetic information in genetically valuable 
male animals. The present study was conducted to test the outcomes of this 
technique using testis tissue from different species of carnivore.  In particular, 
we compared the progression of germ cell development in xenografts from 
neonatal- to pubertal-aged dogs and 8 week-old ferrets. Testis tissue was 
ectopically implanted under the skin on the backs of castrated nude mice and 
subsequently evaluated for testosterone production and establishment of 
spermatogenesis at various time points: 10, 30, and 50 weeks and 10, 20, 25, 
and 30 weeks after grafting, for the dog and ferret, respectively. 75% of dog 
xenografts were recovered whereas 40% of ferret xenografts were harvested. 
Seminal vesicles were collected from the recipient mice and weighed as an 
assay for bioactive testosterone. The weights of seminal vesicles from the 
mice of both species showed no significant difference from the value of 
uncastrated, control nude mice, indicating that the xenografts were producing 
testosterone. Germ cell development in the dog xenografts was quite poor, 
with almost no production of mature sperm regardless of the age of donor 
tissue. Conversely, the ferret testicular xenografts produced differentiated 
germ cells and sperm at the same time as the age-matched controls. These 
data demonstrate dramatic differences in the ability of testicular tissue from 
different donor species of carnivore to establish spermatogenesis following 
ectopic testicular xenografting.  
* Please note that a portion of ferret xenograft procedures were performed by 
Dr. Jim Gourdon, and a detailed analysis of the ferret xenografts is to be 
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performed by him as his contributions to a co-authored manuscript that will 
incorporate the experiments and results described in this chapter.  
 
Introduction 
 Spermatogenesis is a highly complex process to generate male 
gametes continuously throughout the lifetime of a male animal. This process 
begins with spermatogonial stem cells (SSC), which will undergo a dynamic 
process of proliferation and differentiation with extensive support from the 
somatic Leydig and Sertoli cells (Setchell 1978). The complexity of the system 
has been an obstacle to recapitulate and study spermatogenesis in vitro. In 
1994, Brinster et al. introduced spermatogonial stem cell transplantation 
(SSCT) as the first functional assay of SSCs (Brinster and Zimmermann 
1994), and this has greatly accelerated SSC research.  Several years later, the 
technique of testis xenografting was reported as another promising tool to 
study spermatogenesis (Honaramooz, Snedaker et al. 2002).  
 In addition to facilitating research on spermatogenesis, these 
technologies can be used practically as tools to preserve male genetic 
information not only for wildlife conservation but also for human cancer 
patients. When a genetically valuable animal dies or a cancer patient needs 
harsh chemotherapy that can destroy his fertility, cryopreservation of sperm is 
the most common method used to conserve their genetic information for future 
use. Because sperm are terminally differentiated cells incapable of self-
replication and are only produced from sexually mature animals, 
cryopreservation of sperm has some limitations. However, techniques using 
SSC can overcome these limitations: SSC can be harvested throughout an 
animalʼs lifetime after birth and they can produce sperm indefinitely. Therefore, 
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testis xenografting, which preserves spermatogonial stem cells, could provide 
a remarkable potential to preserve male genetic information.  
 Testis xenografting is performed by implanting 1-2 mm3 pieces of testis 
tissue into immunodeficient mice. Over time, the xenografts grow and produce 
sperm in the recipient. It has been shown that sperm produced from 
xenografts can produce offspring as well (Schlatt, Honaramooz et al. 2003). 
Since the first testis xenografting was performed in the mouse, various donor 
species have been used including pigs and goats (Honaramooz, Snedaker et 
al. 2002), hamster and monkey (Schlatt, Kim et al. 2002), cattle (Oatley, 
Reeves et al. 2005; Rathi, Honaramooz et al. 2005), rabbits (Shinohara, Inoue 
et al. 2002), cats (Snedaker, Honaramooz et al. 2004), humans (Schlatt, 
Honaramooz et al. 2006), and horses (Rathi, Honaramooz et al. 2006). In all 
cases thus far, a dramatic decline in success of xenografts has been noted 
when using adult tissue (versus pre-pubertal). Therefore most studies have 
utilized neonatal or pre-pubertal donor tissue. We recently demonstrated that 
in cats, the precise age at which success drops is the onset of puberty when 
meiotic cells first appear in the seminiferous tubules (Kim, Selvaraj et al. 
2007).  
 Although xenografts from many species can produce sperm, the rate of 
progression of spermatogenesis varied among species. Particulary, the cat 
(Felis catus) showed a dramatic delay in producing sperm first in the study of 
Snedaker et al. (Kim, Selvaraj et al. 2007; Snedaker, Honaramooz et al. 2004), 
and then in our study regardless of the age of donor tissue (Kim, Selvaraj et al. 
2007). We noted that the cat is the only carnivore to have been utilized in 
previous studies on testis xenografting. Because about 30% of carnivores are 
listed as endangered (http://www.iucnredlist.org/), and because concerted 
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efforts are needed to save these animals (due to the ecosystem-scale effects 
of trophicc cascades that can result from loss of predators), we set out to 
investigate the efficacy of testis xenografting using donor tissue from other 
carnivore species, namely, domestic dogs (Canis lupus familiaris) and 
domestic ferrets (Mustela putorius furo).  
 
Materials and Methods 
Animals 
 Donor testes from domestic dogs were obtained from castrations at 
research animal facilities and local veterinary hospitals. Three donors each 
were used for the age groups of “Fetal” (gestation day 55-57) and “Neonatal” 
(1-4 weeks old), and four donors each were used for the age groups of 
“Prepubertal” (9-12 weeks old) and “Pubertal” (6 months old). For the ferret 
study, testes were obtained from domestic ferrets (Marshall BioResouces, 
North Rose, NY) undergoing routine surgical castration under general 
anesthesia.  Four ferrets, each aged 8 weeks, were used as donors.  Testes 
from 18-, 28- and 31-week old ferrets were used as controls to match 
approximately the age of donor tissue when the xenografts were collected. All 
samples were stored and transported in sterile saline at 4˚C, and used within 
24 h after collection. The testes were washed in cold PBS and visible blood 
was removed by blotting. One third of each testis was fixed overnight in 
Bouinʼs solution for histological assessment of the donor tissue at the time of 
xenografting. The remaining portion of each testis was processed for 
xenografting.  
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Xenografting procedure 
The tunica albuginea and rete testis were removed and the testis 
parenchyma was cut into specimens measuring 1.5 - 2 mm3. These were kept 
in DMEM containing 100 µg/ml streptomycin sulfate and 100 IU/ml penicillin on 
ice until grafting. Male nude mice (aged 4-8 week, (Tac:Cr:(NCr)-Foxn1[nu], 
Taconic, Germantown, NY) were used as recipients (1-3 mice per donor). 
Anesthesia was induced and maintained with 1.5 - 3.5% isoflurane. Castration 
was performed via a midline abdominal approach, after which an incision was 
made on the dorsal midline and 3 - 8 xenografts were placed under the skin (2 
– 4 grafts on each side, approximately 1 cm lateral of midline, and evenly 
spaced between the shoulders and the flanks). A 5 mm length of 6-0 silk 
(Ethicon, Somerville, NY) was used to mark the site of xenograft placement to 
facilitate retrieval, and to loosely tether the tissue to prevent movement. The 
dorsal incision was closed with skin staples (Braintree Scientific, Inc., 
Braintree, MA). At the end of surgery, buprenorphine (1 mg/kg) was used for 
analgesia. All experimental protocols were reviewed and approved by the 
Institutional Animal Care and Use Committee of Cornell University.  
 
Analysis of xenografts 
The canine testicular xenografts were collected at 10, 30, and 50 weeks 
after xenografting whereas the ferret xenografts were evaluated at 10, 20, 25, 
and 30 weeks after xenografting, corresponding to 18, 28, 33 and 38 weeks of 
age, respectively.  At those time points, one or more larger grafts were excised 
from multiple recipients. The collected xenografts were measured in size and 
fixed in Bouinʼs solution overnight. The fixed xenografts were washed out of 
the Bouinʼs solution into 70% ethanol, and then dehydrated in ethanol prior to 
 73 
embedding in paraffin and sectioning at 4 µm thickness. After mounting on 
slides, each section was deparaffinized with xylene and hydrated with 100% 
and 70% ethanol and water, prior to staining with hematoxylin and eosin. The 
sections were scanned under an Eclipse TE2000-U microscope (Nikon, 
Melville, NY) and images were captured using a Retiga 1300 color camera 
(QImaging corporation, Burnaby, BC, Canada). Statistical analysis was 
performed using KaleidaGraph 4 (Synergy Software, Reading, PA) and 
statistical significance was considered at P < 0.05.  
 
Results 
Histological analysis of canine xenografts 
  As shown in table 3.1, the recovery of xenografts decreased as the 
age of donor tissue approached puberty, ranging from 96 to 67%. At the time 
of xenografting, gonocytes were the only germ cells in the seminiferous cords 
of the fetal testes (Figure 3.1.A). Fetal xenografts rarely supported 
spermatogenesis past spermatocytes, although one xenograft did contain 
elongating spermatids (Figure 3.1.B and C). Testis xenografts from 3 neonatal 
donor dogs were placed into 3 separate recipient mice and in each case 
showed the same failure to support spermatogenesis (data not shown). 
Spermatogonia were observed as the most advanced germ cell types in all 
prepubertal testes prior to xenografting (Figure 3.1.D) and at 10 weeks after 
xenografting (Figure 3.1.E). At 30 weeks after implantation, 7.7 % of recovered 
xenografts had spermatocytes as the most advanced germ cell types (Figure 
3.1.F). Morphologically mature spermatozoa were found in only one out of 15 
grafts collected at 50 weeks (Figure 3.1.G). In the testis xenografts of pubertal 
dogs, post meiotic germ cells were not observed at any time points, and 
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spermatocytes were noted as the most advanced germ cells (Figure 3.2.I, J, 
and K).   
 
 
 
 
 
Table 3.1. Xenografts recovery and parameters of spermatogenesis in 
dog testis xenografts 
 
Most advanced germ cell 
stages in xenografts (%)b 
Age  
% Total 
grafts 
recovereda  
 
Time 
after 
grafting 
(weeks) 
# Grafts 
retrieved 
per time 
point SG SC RS ES Sperm 
30 11 18.2 36.4    Fetal 
(GD 55-57) 95.7 50 11 18.2 36.4 - 9.1  
10 6 83.3     
30 26 19.2 7.7    Prepubertal (4-12 wks) 78.3 
50 15 - 66.7 - 6.7 6.7 
10 17 5.9 58.8    
30 11 - 27.3    Pubertal (6 mos) 67.1 
50 29 3.4 41.4    
a: Total number of xenografts retrieved divided by the total number of grafts 
placed 
b: Total number of xenografts which contained the indicated stage of germ cell 
development divided by the total number of xenografts retrieved at that time 
point, SG: spermatogonia, SC: spermatocytes, RS: round spermatids, ES: 
elongating spermatids, Sperm: spermatozoa  
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Figure 3.1. Cross-sections of seminiferous tubules in canine testis 
xenografts. Panels shown under ʻ0 weekʼ are representative of the 
histological appearance of donor tissue at the time of xenografting. 
Gonocytes were observed in fetal testes at gestation day 55-57 
(Arrowhead in A) and spermatogonia were the most advanced germ 
cells in the prepubertal testes (D). Full spermatogenesis was seen in 
pubertal testes (H) and an arrowhead indicates a cluster of almost fully 
mature sperm in this panel. Xenografts were collected from the different 
donor age groups, fetal (GD 55-57, panels B, C), prepubertal (4-12 wks, 
panels E, F, G) and pubertal (6 mos, panels I, J, K), at 10, 30 and 50 
weeks post grafting. Fetal xenografts were not collected at 10 week 
time point because the small amount of donor testis tissue limited the 
possible number of samples and it was too early to expect germ cell 
development. Spermatocytes and elongating spermatids were the most 
advanced germ cells in testis xenografts using fetal donor tissue at 30 
and 50 weeks after xenografting, respectively (Arrowheads in B and C). 
Testis xenografts from prepubertal donors showed spermatogonia (E), 
spermatocytes (F) and sperm (G) as the most germ cell stages at 10, 
30 and 50 week time points, whereas spermatocytes were the most 
advanced germ cells observed at any time point in testis xenografts 
using tissue from pubertal donors (arrowheads in I, J, and K for 10, 30 
and 50 week time points, respectively). Bar = 15 µm except for panels 
A, D, and H (100 µm). Note that xenografts of testis tissue from all 
donor ages rarely supported spermatogenesis. Images in this figure 
represent the most successful of the xenografts for the respective times 
and age groups. 
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Analysis of ferret xenografts  
 A total of 32 out of 80 ferret testis xenografts (40.0%) were recovered at 
10, 20, 25 or 30 weeks after placement. Primary spermatocytes and 
spermatozoa were the most advanced stages of germ cell development in the 
grafts recovered 10 and 20 weeks after placement, respectively. These 
corresponded exactly with the progress of germ cell development in age-
matched control testes (Figure 3.2). At 25 weeks after xenografting, the 
xenografts continued to produce sperm but some grafts started to show fluid-
distended tubules (Figure 3.3). Although spermatozoa were still present at 30 
weeks, more tubules were distended and some were degenerating. Small 
tubular lumens with no degeneration were observed in the corresponding 
control testes.  
 
Evaluation of xenograft testosterone production 
  Average seminal vesicle weights were 319.7 ± 91.8, 265.0 ± 132.9 and 
148.9 ± 96.5 from the recipients of fetal, prepubertal and pubertal dogs, 
respectively. The seminal vesicle weights of the recipients were compared to 
those of control mice (294.9 ± 16.3), and no significant differences were found. 
These data suggested that the canine testis xenografts, including those from 
pubertal donors, were able to produce bioactive testosterone. For the 11 
recipients bearing ferret grafts, the average seminal vesicle weight was 237.7 
± 130.6 mg, which was not significantly different from controls.  
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Figure 3.2. Histology of ferret seminiferous tubules in age-
matched control and testis xenograft sections. No differentiating 
germ cells were observed in the testes collected from an 8 week old 
ferret (panels A and B). At 18 weeks old, spermatocytes were the most 
advanced germ cells in control testes (arrowhead in panel C). This 
stage was also the most advanced cell type observed in xenografts 
removed 10 weeks after placement (arrowhead in panel D). Full 
spermatogenesis was observed in the testis of a 28 week old ferret (E), 
as well as in a xenograft collected 20 weeks after placement 
(arrowhead in panel F).  
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Figure 3.3. Histological sections of a ferret xenograft collected at 
25-week post grafting. Some seminiferous tubules were fluid distended 
and showed empty lumens (the area indicated by arrowheads in panel 
A), whereas other tubules continued to produce sperm (arrowhead in 
panel B). 
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Discussion 
 In this study, we compared the success and progression of 
spermatogenesis in dog and ferret testis xenografts, in an effort to understand 
the delayed and abnormal spermatogenesis we had observed in xenografts 
using feline testis tissue (Kim, Selvaraj et al. 2007). Put simply, we wondered 
whether the derangements we had observed in feline xenograft 
spermatogenesis were unique to cats or whether they represented a broader 
incompatibility between the testis tissue of carnivores and the environment 
provided by the recipient mice. Ectopic testis xenografting has been performed 
using many different species as donors (Honaramooz, Snedaker et al. 2002; 
Oatley, Reeves et al. 2005; Rathi, Honaramooz et al. 2006; Schlatt, 
Honaramooz et al. 2006; Schlatt, Kim et al. 2002; Shinohara, Inoue et al. 
2002; Snedaker, Honaramooz et al. 2004). However, there have been great 
discrepancies between species in terms of the timing of xenograft sperm 
production versus that seen under normal physiological conditions. Xenograft 
spermatogenesis in the pig (Honaramooz, Snedaker et al. 2002) and primate 
(Honaramooz, Li et al. 2004) showed a decreased time to sperm production 
versus if the testis tissue had been left in the donor. No difference was 
observed in the timing of sperm production of bovine xenografts (Oatley, de 
Avila et al. 2004; Rathi, Honaramooz et al. 2005), and sperm production was 
remarkably delayed in feline xenografts (Snedaker, Honaramooz et al. 2004). 
We also observed delayed germ cell development in cat testis xenografts, and 
documented that this was true regardless of donor age (Kim, Selvaraj et al. 
2007). 
 In the present study, the recovery rates of canine xenografts were 
comparable to those we obtained for cats, 96-67% vs. 82-64%, respectively. In 
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contrast, the ferret xenografts showed lower total recovery rates (40%). In the 
dog, spermatocytes were observed as the most advanced germ cell type in 
neonatal (gestation day 56, which was a few days before the birth) and 
prepubertal (4-12 week old) xenografts at 30 week after placement, which 
should match to  30-42 weeks of age. Considering that the onset of puberty is 
6-9 months old in the dog (Oettle 1993), the progression of spermatogenesis 
is similar to the intact controls and xenografts. However, the support of 
spermatogenesis was remarkably poor in the canine xenografts, particularly 
for the post meiotic cells and sperm production: only 2 and 1 grafts out of a 
total of 125 produced elongating spermatid and sperm, respectively.  
 Although the recovery rate of ferret grafts was slightly less than for 
other species, the progress of germ cell development in the ferret xenografts 
was well matched to that seen in intact control testes. In ferret xenografts, we 
observed spermatocytes at 10 weeks and sperm production at 20 weeks after 
placement. The later appearance of distended tubules is consistent with 
findings in the mouse, in which the tubules seem to degenerate after being 
productive, perhaps as a result of the lack of an outflow tract (Honaramooz, 
Snedaker et al. 2002). The production of high numbers of sperm, the 
apparently normal histological appearance of the productive seminiferous 
tubules, and the apparently normal timing of sperm production in ferret testis 
xenografts in comparison with controls, clearly distinguish this species from 
both canine and feline testis xenografts. In this regard, our study demonstrates 
that the difficulties seen in feline and canine xenografts are not indicative that 
xenografts from all carnivores would fail to support spermatogenesis. Rather, 
differences in success lie at either the species, genus or family levels, but are 
not uniform across the taxonomic order, Carnivora. This finding has important 
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practical implications for wildlife conservation and can help inform future lines 
of research. The factors underlying the differences in ability of testis 
xenografts to support spermatogenesis are not well characterized, with the 
exception of the marmoset (Callithrix jacchus), which has been shown to have 
an endocrinological incompatibility with the recipient mouse, in the form of a 
species difference in the LH receptor (Wistuba, Mundry et al. 2004).  
 Xenografts from both dogs and ferrets actively produced testosterone, 
based on the weight of the seminal vesicles of the recipient mice. This tissue 
is very androgen dependent leading to its ability to be used as a bioassay for 
functional testosterone levels (Rathi, Honaramooz et al. 2006; Schlatt, 
Honaramooz et al. 2003; Schmidt, de Avila et al. 2006). This proved that the 
interaction between host endocrine system and the Leydig cells was 
functionally normal. Interestingly, the dog xenografts that were recovered grew 
large—up to 100 times in volume—and normal tubule and interstitial cell 
architecture was maintained, with the exception of the lack of germ cells. This 
phenomenon might be explained by failure of the canine Sertoli cells to 
interact with the host system and to support spermatogenesis. In the dog, 
there are two predicted isoforms of FSH receptors, which are expressed on 
Sertoli cells. The protein sequence of canine FSH receptor isoform 2 is only 
64% identical to the murine FSH receptor, whereas the sequence of isoform1 
is 84% identical. Further investigation is needed to confirm whether failure to 
respond to murine FSH is responsible for the poor spermatogenesis in the dog 
grafts. In conclusion, the progression of spermatogenesis and the successful 
production of sperm in xenografts largely depend on the nature of the donor 
species. Factors contributing to these species-specific responses are 
unknown, and could derive from the xenograft germ cells or somatic tissues, 
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or from the hormonal interactions between the recipient mouse and the 
xenografts.  
 In this present study, we demonstrated that the progression of 
spermatogenesis was similar to that seen in age-matched controls both in the 
dog and ferret testis xenografts but the support to produce sperm was 
remarkably poor in the dog xenografts. Although testis xenografting is a 
potentially powerful tool to preserve male genetic information, differences 
between species will limit the application of this technique.  
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Recipient preparation and mixed germ cell isolation  
for spermatogonial stem cell transplantation in domestic cats 
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Abstract 
 The loss of genetic diversity poses a serious threat to the conservation 
of endangered species including wild felids. We are attempting to develop 
spermatogonial stem cell transplantation in the cat as a tool to preserve and 
propagate male germplasm from genetically valuable animals, be they 
threatened wild species or lines of cats used as models for inherited diseases. 
In this study, we investigated the use of local external beam radiation 
treatment to deplete the endogenous germ cells of male domestic cats, a step 
necessary to prepare them for use as recipients for transplantation. Testes of 
5 month-old domestic cats were irradiated with a fractionated dose of 3 Gy per 
fraction for three consecutive days. These cats were castrated at 2, 4, 8, 16, 
and 32 weeks post-treatment, and progress of spermatogenesis was 
evaluated histologically and compared against age-matched controls.  Even at 
the latest time points, less than 10% of tubules contained germ cells at any 
stage of meiosis, showing the efficacy of this protocol.  In addition, male germ 
cells were isolated from the testes of domestic cats using a 2-step enzymatic 
dissociation to establish a protocol for the preparation of donor cells. The 
presence and viability of spermatogonia within this population was 
demonstrated by successful transplantation into, and colonization of, mouse 
seminiferous tubules.  The success of these protocols provides a foundation to 
perform spermatogonial stem cell transplantation in the domestic cat.  
 
 88 
Introduction 
The irrevocable loss of genetic diversity in cats due to infertility or the 
death of rare individuals is a tremendous obstacle to the conservation of 
endangered species, as well as to the maintenance of lines of cats used to 
study inherited disease. To maintain the genetic information contained in 
individual males, spermatozoa can be collected pre- or post-mortem and 
cryopreserved. However, reliance on sperm alone has several limitations. For 
example, sperm are terminally-differentiated, haploid cells, which cannot 
replicate themselves and so can only be used for a limited number of breeding 
attempts. Notably, spermatozoa also cannot be collected from sexually 
immature males. Techniques of assisted reproduction based on 
spermatogonial stem cells (SSC) offer several advantages in this regard. 
Unlike mature spermatozoa, SSC replenish their own population while 
concurrently producing daughter cells that undergo meiosis and differentiate 
into sperm during the process of spermatogenesis. Even more significant for 
the purposes of conservation, spermatogonia can be harvested from immature 
males as well as adults, offering a way to preserve genes from animals that 
die prior to sexual maturity. In addition, the use of in vitro culture systems 
might allow for the expansion of populations of SSC (Izadyar, den Ouden et al. 
2003a; Kubota, Avarbock et al. 2004), increasing potential future use of this 
resource. 
Testis xenografting is one of the techniques that can utilize SSC to 
preserve valuable genetic information. This technique is performed by 
transplanting mm-sized cubes of testis tissue from a variety of species into 
immunodeficient mice, in which the xenografts can grow and produce sperm of 
the donor species. Xenografting of testicular tissue into mouse recipients has 
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been successful with tissues isolated from mice, pigs, and goats 
(Honaramooz, Snedaker et al. 2002), hamster and monkey (Schlatt, Kim et al. 
2002), calves (Oatley, Reeves et al. 2005), rabbits (Shinohara, Inoue et al. 
2002), and cats (Snedaker, Honaramooz et al. 2004).  Although testis 
xenografting is relatively easy to perform technically and requires only 
immunodeficient mice regardless of the donor species, this method also has 
its own set of limitations.  For example, it takes a full year for feline sperm to 
be produced from xenografted testis tissue (Snedaker, Honaramooz et al. 
2004), and even if successful, the method provides relatively low numbers of 
donor spermatozoa.  Because the sperm produced are testicular and have not 
undergone epididymal maturation, they can only be used for intra-cytoplasmic 
sperm injection (ICSI) followed by embryo transfer.  From a conservation 
perspective, this is limiting in that it requires the development of both these 
technologies for all species in which it could be used.  In addition, the relatively 
short lifespan of immunodeficient mice would limit the time available to retrieve 
xenograft-derived sperm. This would necessitate the development of 
cryopreservation methods for long-term storage of testis tissue cubes that 
preserve the multiple cell types and tissue architecture, a feat more difficult 
than the cryopreservation of single cell suspensions.  
Spermatogonial stem cell transplantation (SSCT) in the mouse was 
first reported in 1994 (Brinster and Zimmermann 1994). In this technique, 
either enriched populations of spermatogonia, or mixed cell populations 
including spermatogonia, are placed within the lumens of the seminiferous 
tubules of a recipient. Placement is performed either by retrograde injection 
through the efferent ducts [rodents; (Ogawa, Arechaga et al. 1997)], or via 
retrograde injection into the rete testis [large animal models; (Honaramooz, 
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Behboodi et al. 2003; Honaramooz, Megee et al. 2002). This technique has 
several advantages over testis xenografting.  Namely, there is the potential for 
increased numbers of sperm to be collected and these sperm will undergo 
epididymal maturation, both of which might allow the sperm produced to be 
used for other technologies of assisted reproduction such as in vitro 
fertilization or artificial insemination.  In addition, depending upon the species 
of recipient, sperm could be collected via electro-ejaculation or by use of 
manual stimulation or artificial vaginas over a period of time longer than the 
lifespan of a rodent. SSCT could allow sperm collection over a time period 
covering multiple estrus cycles and give more attempts to generate offspring 
carrying that maleʼs genetic information. Xenogeneic SSCT, in which the donor 
and recipient are different species, has been performed using several species 
as donors and mice as recipients (Clouthier, Avarbock et al. 1996; Ogawa, 
Dobrinski et al. 1999a). However, if the phylogenetic distance between donor 
and recipient is too wide, the donor spermatogonia can colonize but 
spermatogenesis will not occur (Dobrinski, Avarbock et al. 1999; Nagano, 
McCarrey et al. 2001). Therefore, we sought to investigate methods that would 
allow the use of SSCT in felids, for the purpose of preserving the genetic 
diversity of genetically valuable cats.  
To perform SSCT in different species of animals, two distinct steps 
must be achieved prior to the actual introduction of donor germ cells. First, a 
recipient animal should have its endogenous germ cells depleted, so that the 
introduced cells will have improved access to the basal compartment of 
seminiferous tubules and so that there is a higher relative yield of donor-
derived sperm (Brinster, Ryu et al. 2003). Several techniques have been used 
to reduce or deplete endogenous male germ cells such as irradiation 
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(Meistrich, Hunter et al. 1978; Van Beek, Meistrich et al. 1990; Withers, Hunter 
et al. 1974), chemotherapeutic drugs (Brinster, Ryu et al. 2003; Ogawa, 
Arechaga et al. 1997) and cold ischemia treatment (Young, Goldstein et al. 
1988). External beam radiation treatment is a useful tool in this regard, 
because the germ cells are highly radiosensitive (Dym and Clermont 1970; 
Huckins 1978), and the Sertoli cells and Leydig cells are relatively 
radioresistant (Dym and Clermont 1970; Joshi, Yick et al. 1990; van der Meer, 
Huiskamp et al. 1992; Vergouwen, Huiskamp et al. 1994). A number of 
radiation treatment protocols have therefore been tested and used to prepare 
recipients of several species for SSCT (Izadyar, den Ouden et al. 2003b; 
Schlatt, Foppiani et al. 2002). Second, once having prepared the recipient, a 
cell suspension containing spermatogonia must be isolated from donor testes. 
Optimally, mixed germ cell populations would be enriched in spermatogonia 
(Shinohara and Brinster 2000; Shinohara, Orwig et al. 2000), although the lack 
of stem cell markers in species other than rodents and primates makes such a 
step premature at this time. Spermatogonia are situated in the basal 
compartment of seminiferous tubules, located between Sertoli cells and just 
above the underlying basement membrane and peritubular myoid cells. In the 
interstitial space between tubules, blood and lymphatic vessels, connective 
tissue and Leydig cells are positioned. Collection of suspensions of 
individualized male germ cells has commonly utilized sequential enzymatic 
digestion (Bellve, Millette et al. 1977; Honaramooz, Megee et al. 2002). Such 
protocols typically involve isolation of seminiferous tubules from the interstitial 
tissue, and then dissociation of individual germ cells from within the tubules. 
Although germ cell dissociation has been performed in several species, it has 
not yet been reported in domestic cats. 
 92 
In this study, we report successful protocols for the depletion of 
endogenous germ cells in domestic cats by local external beam radiation 
treatment and for the enzymatic dissociation of testis tissue to yield mixed 
male germ cells containing viable spermatogonia, two critical steps necessary 
to perform SSCT in felids.  
 
Materials and Methods 
Reagents 
All reagents were purchased from Sigma (St. Louis, MO), unless 
otherwise noted. Ketamine HCl (Fort Dodge Laboratories Inc, Fort Dodge, IO), 
diazepam and isoflurane (Abbott Laboratories, North Chicago, IL) were used 
for the induction and maintenance of anesthesia in the experimental cats. For 
histology, 100% and 70% ethanol (Pharmco, Brookfield, CT), hematoxylin, and 
eosin (Electron Microscopy Sciences, Fort Washington, CA) were used. 
Trypan blue was purchased from Gibco (Carlsbad, CA) for cell viability 
analysis. 
 
Animals 
Domestic short haired cats (Felis domesticus), were obtained from 
Liberty Research Inc. (Waverly, NY). The cats were housed in groups of four 
under standard lighting (12L:12D) and allowed access to food and water ad 
libitum.  NCr Swiss nude (nu/nu) mice aged 10-20 weeks were used as 
recipients for transplantation (Taconic, Germantown, NY).  All experimental 
protocols were reviewed and approved by the Institutional Animal Care and 
Use Committees of Cornell University or the University of Pennsylvania.  
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Local external beam radiation of testes  
5 month-old domestic cats (n=10) were anesthetized with ketamine 
HCl (5mg/kg i.v.) and diazepam (0.5 mg/kg i.v.) and maintained by masking 
with isoflurane (1 - 3 %). Each cat was positioned in sternal recumbency using 
a vacuum cushion (Vac-Lok,™ Med-Tec, Orange City, IO). The hind limbs 
were extended caudo-laterally to facilitate alignment of the long axes of the 
testes parallel to the body axis. Gauze bandage was loosely tied around the 
base of the scrotum to effect partial immobilization of the testes in the scrotum 
during the procedure. Tissue equivalent material was placed around the 
scrotum to protect surrounding tissue, and 1 cm of tissue equivalent material 
was placed on the surface of the scrotum to provide uniformity of radiation 
dose delivery (Figure 4.1). The testes were irradiated with a 6 MV linear 
accelerator (7 MeV electrons, dose rate of 300 MU/minute). A 3 cm diameter 
cone was used to collimate the electron beam to irradiate both testes while 
minimizing exposure of surrounding normal tissue. A fractionated dose of 3 Gy 
was applied to the testes daily for three consecutive days for a total dose of 9 
Gy per animal. As discussed below, this treatment regimen was based on 
findings in other species that suggested fractionated protocols to be more 
efficacious than those involving just one exposure. 
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Figure 4.1.  Positioning of the testes for external beam radiation 
treatment. The cat was positioned on a vacuum cushion repositioning 
device and the beam was centered precisely between the two testes 
(panel A). Panel B shows the collimating cone atop the tissue equivalent 
material. 
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Testis collection and processing 
Cats were castrated after induction of anesthesia as described above 
and testes along with the epididymides were collected at time points 2, 4, 8, 
16, and 32 weeks after treatment (n=2 for each time point). The testes were 
halved along the longitudinal axis and fixed in Bouinsʼ solution. Testes were 
also obtained from routine castrations of untreated cats at local veterinary 
hospitals. Age-matched specimens served as controls and were processed 
identically as the treated testes.  
 
Detection of spermatozoa 
The cauda epididymides obtained from the irradiated animals and from 
the age-matched controls were minced and incubated in PBS (pH 7.4) at 37˚C 
for 15 minutes to swim out spermatozoa. Collected sperm was observed under 
a light microscope at 100X magnification to evaluate their presence, 
appearance, and concentration. Total numbers of sperm were then calculated 
by multiplying the concentration by the total volume. Comparisons of 
epididymal sperm numbers were performed by an unpaired Studentʼs t-test 
(Origin 7.0 Software, OriginLab Corporation, Northampton, MA). Statistical 
significance was assumed at P < 0.05. 
 
Testis histology and evaluation 
The fixed testes were washed out of the Bouinsʼ solution into 70% 
ethanol, then dehydrated in ethanol prior to embedding in paraffin and 
sectioning at 4 mm. After mounting on slides, each section was deparaffinized 
and hydrated with xylene, and then 100% and 70% ethanol, prior to staining 
with hematoxylin and eosin. The sections were scored for the presence of 
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meiotic cells and stage of spermatogenesis in at least 500 seminiferous tubule 
cross sections per testis. Then the percents of tubules containing 
spermatocytes, round spermatids, and elongating spermatids were calculated. 
The results were compared with those obtained from age-matched, untreated 
controls. Images were captured using an Eclipse TE2000-U microscope 
(Nikon, Melville, NY) and Retiga 1300 color camera (QImaging corporation, 
Burnaby, BC, Canada). 
 
Germ cell dissociation  
 Spermatogenic cells were collected from testes obtained from routine 
castrations of pre-pubertal, pubertal and young adult animals at a local 
veterinary hospital and animal shelters.  A two-step enzymatic digestion was 
performed, as described by Dobrinski et al (Dobrinski, Avarbock et al. 1999). 
Hankʼs Balanced Salt Solution (HBSS) containing 0.44 mM KH2PO4, 137 mM 
NaCl, 5.36 mM KCl, 4.2 mM NaHCO3, 0.44 mM KH2PO4 and 5 mM glucose 
was prepared and sterilized by passing through a 0.22 mm filter (Millipore, 
Billerica, MA). After rinsing the testis in this medium, visible blood was blotted 
and the testis was rinsed again. The tunica albuginea and grossly visible 
connective tissue associated with the rete testis were then removed. The 
remaining tissue was incubated in HBSS containing 1 mg/ml collagenase for 10 
minutes at 34 °C in a shaking water bath set at 110 oscillations/min. The 
dispersed seminiferous tubules were isolated by allowing them to sediment in 
HBSS on ice and decanting the supernatant. This step was repeated until the 
supernatant was clear. The isolated seminiferous tubules were then incubated 
in HBSS containing 1.25 mg/ml trypsin and DNaseI (50 mg/ml) as above. The 
resultant cell suspension was filtered through a 70 mm nylon mesh (BD Falcon, 
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San Jose, CA), washed by centrifugation at 600 x g for 5 minutes at room 
temperature for three times, and resuspended in Dulbeccoʼs Modified Eagle 
Medium (DMEM) containing 100 mg/ml streptomycin sulfate and 100 IU/ml 
penicillin. Cell viability was analyzed by incubation with 0.4 % trypan blue for 10 
min at 37 ˚C. 
 
Assessment of the presence and viability of SSC isolated during germ cell 
dissociation 
The individualized germ cell population produced by the dissociation 
protocol was examined for the presence of viable SSC by methods similar to 
those published previously (Dobrinski, Avarbock et al. 1999).  Briefly, a 
suspension of individual germ cells was prepared as above. Twenty NCr 
Swiss nude mice were treated with busulfan (40 mg/kg) to deplete 
endogenous male germ cells.  Transplantation of the individualized male germ 
cells into the seminiferous tubules of these testes involved a retrograde 
injection through the efferent ducts of approximately 10 µl of cell suspension 
(108 cells/ml). To analyze the success of transplantation, recipient testes were 
collected between 48 and 456 days post-transplantation.  The tunica 
albuginea was removed, and the seminiferous tubules were gently dispersed 
with collagenase prior to fixation in freshly-prepared 4% paraformaldehyde for 
2 h at 4˚C. Whole-mount immunohistochemistry using a polyclonal antibody 
against cat testicular cells [prepared and purified as described for rabbit testis-
specific and dog testis-specific antisera (Dobrinski, Avarbock et al. 1999)] was 
performed to detect the presence of feline cells in the recipient mouse testes. 
Cells were visualized with 3-amino-9-ethylcarbazole following incubation with 
biotinylated, species-specific IgG and avidin coupled to horseradish 
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peroxidase (Dobrinski, Avarbock et al. 1999). Controls included 
immunohistochemistry in the absence of the primary antiserum (control for 
specificity of detection), and immunohistochemistry of tubules soon after 
injection (positive control). 
 
Results 
Evaluation of epididymal spermatozoa 
Only rare, immotile epididymal sperm were observed at 2 weeks after 
treatment. No sperm were found in the cauda epididymides of castrated testes 
at 4, 8, and 16 weeks after external beam radiation treatment, whereas 
epididymal sperm were seen in all controls at those times. At 32 weeks after 
treatment, sperm were collected from cauda epididymides of treated animals, 
as well as controls. The average total number of sperm collected from both 
epididymides of treated testes at 32 weeks was 3.27 ± 1.7 x106 (average, n = 
2), significantly lower than the average total number of sperm collected from 
age-matched testes which was 7.73 ± 0.4 x107 (average, n = 2).  
 
Effect of external beam radiation on male germ cell development 
 The rationale behind the choice of the parameters of the external beam 
radiation protocol, as well as the choice of age of the cats at time of treatment, 
are discussed below.  At 2 and 4 weeks after treatment, <1.5% of seminiferous 
tubules contained meiotic cells, compared with >50% of tubule cross sections 
in age-matched controls (Table 4.1). In addition, most cross sections of 
tubules showed disarranged Sertoli cells (Figure 4.2.A and 4.2.C). At 8, 16, 
and 32 weeks post-treatment, 4 – 9 % of seminiferous tubules contained 
spermatocytes, whereas full spermatogenesis was seen in all tubules in age- 
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Table 4.1. 
Progression of spermatogenesis in treated and untreated, control testes 
 
 
% of tubule cross sections 
containing: 
% of tubule cross sections 
in age-matched controls 
containing: 
Time 
after 
treatment 
(weeks) SC* RS* ES* Sperm SC RS ES Sperm 
2 1.4 ± 1.58 
1 ± 
3.16 
0.1 ± 
0.37 0 ± 0 
37 ± 
4.06 
11.6 ± 
8.01 
0 ± 
0 0 ± 0 
4 0.4 ± 0.84 
0.4 ± 
0.52 
0.5 ± 
0.71 0 ± 0 
62.8 
± 
6.45 
55 ± 
6.51 
49.2 
± 
4.76 
15.8 ± 
3.83 
8 8.9 ± 4.25 
1.1 ± 
1.20 
0.4 ± 
0.52 0 ± 0 
68.2 
± 
5.72 
41.6 ± 
10.64 
48.4 
± 
6.42 
13.6 ± 
2.30 
16 5.7 ± 5.51 
5.6 ± 
2.79 
2.9 ± 
2.81 0 ± 0 
71.2 
± 
3.83 
59.4 ± 
5.41 
43.6 
± 
8.53 
19.8 ± 
4.09 
32 4.1 ± 4.91 
1.6 ± 
2.11 
1.9 ± 
2.45 
0.7 ± 
1.33 
74.6 
± 
7.64 
53.2 ± 
5.89 
50.2 
± 
2.39 
29.2 ± 
7.66 
 
*SC: spermatocytes, RS: round spermatids, ES: elongating spermatids  
Two treated animals and one untreated control animal were examined for each 
time point.  Values are expressed as the mean percentage of tubule cross-
sections showing a given stage of spermatogenesis, + the standard deviation.  
Values were generated by counting 100 tubule cross-sections within 5, non-
sequential histological sections of each testis, and generating mean and 
standard deviation using Origin 7.0 software. 
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matched controls (Table 4.1 and Figure 4.2). At 32 weeks after treatment, a 
very small number of tubules (< 1%) had sperm, compared with age-matched 
controls (Figure 4.2.I and 4.2.J). There was no apparent change in the 
interstitial cell population between irradiated and untreated testes (Figure 4.2). 
 
Isolation of mixed germ cells  
Successful mixed germ cell isolation in the cat relied upon protocols 
more similar to those used in large animal models than rodents, due to the 
density of the connective tissue within the tunica albuginea. Removal of the 
testis parenchyma from this capsule and from connective tissue associated 
with the rete was performed by sharp dissection. This decreased the time of 
exposure to collagenase and resulted in less damage to the seminiferous 
tubules. Similar to male germ cell dissociation from rodent testes, collagenase 
treatment largely removed interstitial Leydig cells, endothelial cells, and blood 
cells. The seminiferous epithelium was then dissociated into a suspension of 
single cells when incubated with 1.25 mg/ml trypsin. After washing, the 
resultant mixed cell suspension included spermatogonia, spermatocytes, and 
round and elongating spermatids (data not shown).  This protocol was used 
successfully on testes from pre-pubertal, pubertal, and adult cats.  
Approximately 90% of the cells excluded trypan blue, suggesting viability.  
Because of the large inter-cellular bridges connecting male germ cells 
(Ravindranath, Dettin et al. 2003), spermatids often coalesced into larger, 
multi-nucleated cells (data not shown).  This phenomenon is also seen during 
the separation of murine male germ cells (Bellve, Cavicchia et al. 1977).   
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Figure 4.2.  Histological appearance of irradiated and age-
matched, untreated control testes.  Irradiated testis tissue collected 
at 2 (panel A; the arrow head points to a Sertoli cell), 4 (panel C), 8 
(panel E; the arrow head points to a spermatocyte), 16 (panel G; the 
arrow head points to a spermatocyte, and the arrow to an elongating 
spermatid) and 32 (panel I; the arrow points to a spermatocyte, and 
the arrowhead to spermatozoa) weeks after irradiation. Untreated 
control, age-matched testis tissue corresponding to 2 (panel B), 4 
(panel D), 8 (panel F), 16 (panel H) and 32 (panel J) weeks after 
irradiation (200X). 
 
 102 
 
 103 
Assessment of the presence and viability of SSCʼs isolated during germ cell 
dissociation 
To demonstrate that viable SSCʼs were contained within the mixed cell 
population produced by the dissociation procedure, the cell suspension was 
injected via the efferent ductules into the seminiferous tubules of germ cell-
depleted mice. As has been found with other xenogeneic SSCT trials 
(Dobrinski, Avarbock et al. 1999), the feline SSC were able to colonize the 
murine seminiferous tubules but the environment within them was not 
supportive of feline spermatogenesis. Using whole mount 
immunohistochemistry, 19 of 20 recipients stained positive with an antiserum 
that recognized feline testicular cells, and this staining was present in 
recipients throughout the time period observed (Figure 4.3). 
 
 
 
Figure 4.3. Detection of cat testis cells in mouse seminiferous 
tubules. Injected feline testicular germ cells colonized mouse 
seminiferous tubules and stained with an antibody specific for cat 
testicular cells in whole-mount immunohistochemistry on 63 days (panel 
A, 16X), 120 days (panel B, 40X) and 430 days (panel C, 16X) after 
transplantation. The negative control of tubules from testes receiving 
transplanted feline germ cells but incubated in the absence of primary 
antibody revealed no staining (data not shown).  
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Discussion 
 SSCT offers a powerful complement to the collection of mature 
spermatozoa in efforts to preserve the breeding potential of males. These 
benefits are based on the fact that spermatogonia are stem cells and can 
therefore replenish their own population, while simultaneously producing 
sperm on a renewable basis. This technique has been performed using SSC 
from rodents (Clouthier, Avarbock et al. 1996; Ogawa, Arechaga et al. 1997; 
Ogawa, Dobrinski et al. 1999a), large domestic animals (Dobrinski, Avarbock 
et al. 2000; Honaramooz, Behboodi et al. 2003; Honaramooz, Megee et al. 
2002; Izadyar, den Ouden et al. 2003b), dogs and rabbits (Dobrinski, 
Avarbock et al. 1999), and primates (Nagano, McCarrey et al. 2001). To make 
the technique effective for the preservation of threatened or endangered felids, 
preparation of recipient testes and donor germ cells in a suitable model is 
crucial.  
 The first step necessary for SSCT is the preparation of the recipient 
testis, which involves a reduction of the endogenous SSC population. This has 
two purposes: it increases the success of colonization by opening up the 
appropriate "niches" for the transplanted SSC (Spradling, Drummond-Barbosa 
et al. 2001), and it improves the relative yield of donor-derived versus 
recipient-derived sperm.  To accomplish this, we opted to use fractionated 
external beam radiation treatment, which has been demonstrated to be an 
efficient method for germ cell depletion, while also avoiding the complications 
of systemic drug treatments such as busulfan, a DNA alkylating agent that 
destroys proliferating cells. Busulfan can therefore affect proliferating cells 
elsewhere in the body, such as in the bone marrow, as well as endogenous 
germ cells (Ogawa, Dobrinski et al. 1999b).  The testis has been characterized 
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as having radiosensitive cells (the male germ cells, especially spermatogonia) 
and radioresistant cells (the supporting somatic cells) (Dym and Clermont 
1970; Huckins 1978; Joshi, Yick et al. 1990; van der Meer, Huiskamp et al. 
1992; Vergouwen, Huiskamp et al. 1994).  In the human, very low doses 
(<0.35 Gy) result in a sometimes transitory depletion of spermatogenesis, low 
doses (<2 Gy) affect primarily germ cells but on a more permanent basis, and 
doses in excess of 20 Gy begin to affect Leydig cells (Shalet 1993).  In bovine 
calves, a single dose of 10-14 Gy was sufficient to eliminate spermatogenesis 
in 60% of the tubules (Izadyar, den Ouden et al. 2003b).  When pre-pubertal 
rats were irradiated with a single dose of 3 Gy, all the research animals 
showed a resumption of endogenous spermatogenesis by 70 days post-
treatment (Guitton, Touzalin et al. 2000).  A two-day, fractionated ionizing 
radiation protocol was described for use in mice, in which a dose of 1.5 Gy 
was followed by a dose of 12 Gy. At 21 weeks post-treatment, endogenous 
spermatogenesis was reduced to <10% of normal levels, suggesting that 
fractionated radiation protocols might improve duration of effect (Creemers, 
Meng et al. 2002). These varied results show that species, dosage and 
regimen, and the age of the subject might have significant effects on the long-
term outcome of treatment. No large-scale studies comparing the effects of 
these variables on the efficacy of different irradiation protocols have been 
performed. The protocol reported herein for the cat was therefore devised to 
have a focal as opposed to systemic effect and to utilize a fractionated low-
dose regimen as most likely having a longer-term effect. The protocol was 
performed at a dose consistent with previous successful reports in the 
literature. Our results demonstrated that when administered to the testes of 5 
month-old domestic cats, this fractionated protocol of 3 Gy/day for three 
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consecutive days successfully depleted endogenous male germ cells. We 
chose this age for technical reasons, including that the testes at that age are 
of sufficient size to manipulate for external beam radiation as well as being 
sized appropriately for any subsequent transplantation procedures. Older cats 
were not used in the irradiation study for several reasons.  First, the presence 
and subsequent death of higher numbers of germ cells might increase the time 
required until a transplant could be performed successfully.  Transplantation 
will not be performed immediately after irradiation to give the Sertoli cells the 
opportunity to remove dead germ cells, and increase access to stem cell 
niches along the basement membrane.  Second, if transplantation were to be 
performed for the purpose of breeding with donor-derived sperm, then there 
would be a desire to have as long a lifespan as possible post procedure so 
that sperm could be collected over the time period required. 
Spermatogenesis in domestic cats usually begins when 5 or 6 months 
old (Tsutsui, Kuwabara et al. 2004), and the spermatogenic cycle takes 46.8 
days (Franca and Godinho 2003).  At 2 weeks post-treatment, rare sperm 
were collected from the epididymides, suggesting that spermatogenesis had 
begun in isolated areas of individual tubules before treatment, sometime 
during their fourth month.  No epididymal sperm were found from the irradiated 
testes at 4, 8, and 16 weeks after treatment. Sperm were collected from the 
irradiated animals at 32 weeks after treatment; however, the number of sperm 
was over 20-fold less than epididymal sperm of normal young adult cats. 
These results showed that the current radiation protocol depleted most of the 
spermatogonia but didnʼt destroy the ability of those that remained to complete 
spermatogenesis, nor did it destroy the ability of the Leydig cell and Sertoli cell 
populations to support spermatogenesis. Our observations of the tubules in 
 107 
cross section supported this conclusion. Despite the loss of any meiotic cells 
and most SSC, and the disorganization of Sertoli cells seen at 2 and 4 weeks 
after treatment, reorganization of the architecture of the seminiferous 
epithelium occurred between 4-8 weeks, and spermatocytes began to be 
observed by week 8.  The timing of this recovery suggests that approximately 
4-8 weeks post-treatment would be optimal for SSCT.  
Prior to transplantation, donor SSC must be separated from other cells 
within the testis. It is optimal to transplant populations of mixed germ cells 
enriched in SSC (Shinohara and Brinster 2000; Shinohara, Orwig et al. 2000). 
However, given the absence of any known cell surface markers for SSC in 
cats, we sought to begin by separating mixed populations of feline male germ 
cells from testicular somatic cells. Protocols for the preparation of isolated 
male germ cells are species-specific because each species has its own 
anatomical characteristics, such as the relative amounts of connective tissue 
between tubules, lobulation, and the ease of removing the tunica. For this 
reason, we compared two protocols, those of Bellvé et al (Bellve, Millette et al. 
1977) and Dobrinski et al (Dobrinski, Avarbock et al. 1999), the latter of which 
proved more efficient for domestic cats. Before exposure to digestive 
enzymes, two mechanical steps were required: removal of testicular vessels 
reduced contamination with blood, and removal of the testicular capsule and 
grossly visible connective tissue associated with the rete testis facilitated a 
more uniform digestion of the testicular parenchyma. A sequential enzymatic 
digestion was then used to individualize a population of mixed cells. As in the 
mouse, treatment with trypsin led to the loss of developing flagella in 
elongating spermatids and the appearance of some multi-nucleated round 
spermatids.  With this protocol, we obtained mixed germ cells with minimal 
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visual contamination of blood cells and interstitial cells.  In the future, the 
enrichment of SSCs within this mixed germ cell milieu will be pursued once 
SSC surface markers are identified in felids. 
The presence of viable SSC within this population was demonstrated 
by the successful colonization of feline cells within murine seminiferous 
tubules, although as with other donor species, the environment within the 
murine seminiferous epithelium did not support feline spermatogenesis. 
Because there is no antibody specific for cat spermatogonial stem cells, we 
utilized an antiserum made against feline testicular cells to recognize cells of 
feline origin within the murine seminiferous tubules. In 19/20 recipient mice, 
cells staining positive were found. Typically, the immunoreactive cells were 
single or arranged in small groups along the basement membrane, indicating 
colonization and initial proliferation of feline type A spermatogonia in the 
mouse seminiferous tubules. These data verified the viability of feline SSC 
within the dissociated cell population.  Together with the demonstration of a 
successful irradiation protocol for depletion of endogenous male germ cells in 
the cat testis, these data provide a foundation upon which to perform 
spermatogonial stem cell transplantation in the feline model system. 
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CHAPTER 5 
Production of donor-derived sperm  
after spermatogonial stem cell transplantation in the dog 
Kim, Y., Turner, D., Nelson, J., Dobrinski, I., McEntee, M. and Travis, A.  
J. 2008. Production of donor-derived sperm after spermatogonial stem 
cell transplantation in the dog. Reproduction. 136(6):823-831 
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Abstract 
 Spermatogonial stem cell transplantation offers unique approaches to 
investigate spermatogonial stem cells (SSC) and to manipulate the male 
germline. We report here the first successful performance of this technique in 
the dog, which is an important model of human diseases. First, we 
investigated an irradiation protocol to deplete endogenous male germ cells in 
recipient testes. Histologic examination confirmed >95% depletion of 
endogenous SSC, but retention of normal testis architecture. Then, five month-
old recipients (n=5) were focally irradiated on their testes prior to 
transplantation with mixed seminiferous tubule cells [fresh (n=2) or after two 
weeks of culture (n=3)]. The dogs receiving cultured cells showed an 
immediate allergic response, which subsided quickly with palliative treatment. 
No such response was seen in the dogs receiving fresh cells, for which a 
different medium was used. 12 months post injection, recipients were 
castrated and sperm was collected from epididymides. We performed 
microsatellite analysis comparing DNA from the epididymal sperm with 
genomic DNA from both the recipients and the donors. We used 6 markers to 
demonstrate the presence of donor alleles in the sperm from one recipient of 
fresh mixed tubule cells. No evidence of donor alleles was detected in sperm 
from the other recipients. Using quantitative PCR based on single nucleotide 
polymorphisms, about 19.5% of sperm were shown to be donor-derived in the 
recipient. Our results demonstrate the first successful completion of SSCT in 
the dog, an important step toward transgenesis through the male germline in 
this valuable biomedical model. 
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Introduction 
Spermatogonial stem cell transplantation (SSCT) was first reported in 
the mouse (Brinster and Zimmermann 1994). In this technique, mixed germ 
cell populations containing spermatogonia, often enriched to some degree, are 
placed within the lumens of the seminiferous tubules of a recipient. Since the 
first report, isolated germ cells from various donor species including rat 
(Clouthier, Avarbock et al. 1996; Ogawa, Arechaga et al. 1997), hamster 
(Ogawa, Dobrinski et al. 1999a), rabbit and dog (Dobrinski, Avarbock et al. 
1999), primate (Nagano, McCarrey et al. 2001), bull (Oatley, de Avila et al. 
2002) and cat (Kim, Selvaraj et al. 2006) have been transplanted into mouse 
testes. Rats and hamsters were able to produce sperm in the recipient mouse 
testes, whereas the other species showed colonization of stem cells but not 
spermatogenesis. These studies showed that the phylogenetic distance 
between recipients and donors was a strong determinant of whether the 
recipient environment would support donor spermatogenesis.  
Allogeneic transplantation has been performed in the goat 
(Honaramooz, Behboodi et al. 2003; Honaramooz, Megee et al. 2007) and pig 
(Honaramooz, Megee et al. 2002). Such transplantation between con-specific 
individuals is desired for many practical and experimental purposes. In 
addition, transplantation between species might have value for the 
conservation of endangered wildlife. Optimization of SSCT in diverse species 
requires several steps. In addition to a close phylogenetic relationship with the 
donor, an ideal recipient would have its endogenous germ cells depleted. This 
would give introduced SSC improved access to the basal compartment of 
seminiferous tubules, allowing more room for colonization and expansion 
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within the stem cell niche, and would ultimately result in a higher relative yield 
of donor-derived sperm (Brinster, Ryu et al. 2003).  
Two techniques have been widely used to reduce or deplete 
endogenous male germ cells in recipients: focal irradiation (Izadyar, den 
Ouden et al. 2003; Schlatt, Foppiani et al. 2002) and chemotherapeutic drugs 
(Brinster, Ryu et al. 2003; Ogawa, Arechaga et al. 1997). In non-rodent 
animals, focal irradiation can provide an advantage of not inducing systemic 
effects in the recipient, whereas the systemic effects of chemotherapeutics will 
vary between species, as well as with the nature of the drug, its dose, and 
route of administration. Once the recipient testis has been prepared, 
transplantation is performed either via retrograde injection through the efferent 
ducts [rodents (Ogawa, Arechaga et al. 1997)], or into the rete testis [large 
animal models (Herrid, Vignarajan et al. 2006; Honaramooz, Behboodi et al. 
2003; Honaramooz, Megee et al. 2002; Izadyar, den Ouden et al. 2003)]. An 
additional concern in SSCT is the potential for rejection of the introduced cells 
by the recipientʼs immune system. To overcome this problem, matching the 
strains of donors and recipients was addressed in mice (Brinster and 
Zimmermann 1994). In xenogeneic transplantation, in which cells from 
different donor species were transplanted into mice, immunodeficient mice 
were used to avoid rejection (Clouthier, Avarbock et al. 1996; Dobrinski, 
Avarbock et al. 1999; Dobrinski, Avarbock et al. 2000; Ogawa, Dobrinski et al. 
1999b).  However, in several species heterologous transplantation between 
individuals within the same species has been shown to be successful even in 
the absence of modulation of the recipientʼs immune system (Herrid, 
Vignarajan et al. 2006; Honaramooz, Behboodi et al. 2003; Honaramooz, 
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Megee et al. 2002). Thus, several aspects of this technology require species-
specific testing and optimization. 
Stem cell-based technologies such as SSCT potentially offer both 
clinical and basic scientific applications. Transplantation of SSC from wild-type 
mice into the testes of mice having genetic infertility showed successful 
restoration of spermatogenesis in the recipient testes (Rilianawati, Speed et al. 
2003). Thus SSCT has been suggested to be useful to preserve fertility in both 
human and non-human animals, such as for human patients receiving 
chemotherapy (Fujita, Ohta et al. 2005; Fujita, Tsujimura et al. 2006) or wildlife 
conservation (Pukazhenthi, Comizzoli et al. 2006). From a basic scientific 
perspective, SSCT can be used to investigate the fundamental characteristics 
of SSC (Kent Hamra, Chapman et al. 2005; Kubota, Avarbock et al. 2003; 
Nagano, Avarbock et al. 1999; Parreira, Ogawa et al. 1998). Furthermore, 
because the male germline can be manipulated in the SSC prior to 
transplantation, SSCT can be used to generate transgenic animals 
(Honaramooz, Megee et al. 2007; Kanatsu-Shinohara, Ikawa et al. 2006; 
Nagano, Brinster et al. 2001; Ryu, Orwig et al. 2006).   
Over 360 naturally-occurring canine genetic diseases have been shown 
to have counterparts in humans, including various forms of cancer (Lingaas, 
Comstock et al. 2003), blindness (Acland, Aguirre et al. 2005), and orthopedic 
defects (Athanasiou, Agarwal et al. 1995). Moreover, diseases such as 
muscular dystrophy and bleeding disorders (Tsai, Clark et al. 2007) have been 
shown to involve the same genes in both species. More than 400 different dog 
breeds have been produced by selective breeding, many of which originate 
from only a few founders and/or have undergone population bottlenecks. Many 
purebred dogs have unique phenotypic traits including susceptibility to certain 
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genetic diseases. Thus the dog is an outstanding model in which linkage 
analysis can be used to identify genes as candidates for causing a specific 
phenotype. Development of canine transgenesis will provide new opportunities 
for verification that identified genes are actually causative of such phenotypes 
(e.g. when that gene is placed in a different genetic background), and for 
studying mechanisms that cause, and developing therapies that treat, both 
human and canine diseases. We therefore set out to verify an irradiation 
method for recipient testis preparation and to perform SSCT in the dog, as 
needed steps toward transgenesis in this model system. We demonstrate for 
the first time evidence of successful SSCT in the dog, helping achieve these 
goals. 
 
Materials and Methods 
Experimental design 
The first part of this study involved confirmatory testing of a protocol to 
deplete endogenous male germ cells in dogs through the use of focal 
irradiation. Prepubertal dogs had their testes irradiated and then the testicular 
architecture and extent of recovery of spermatogenesis were tested 8 weeks 
after treatment. In the second phase of the study, mixed germ cells were 
isolated from donor testes and were transplanted into prepubertal recipient 
dogs that had had their germ cells depleted using that irradiation protocol. 
Sperm were collected from the recipients and genotyped to determine the 
origin and the relative contributions from endogenous versus donor 
spermatogenesis. All experimental protocols were reviewed and approved by 
the Institutional Animal Care and Use Committee of Cornell University. 
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Preparation of recipients 
Two 5 month-old hound mongrels (Marshall BioResources, North Rose, 
NY) had their testes subjected to focal external beam radiation to deplete their 
endogenous germ cells as described (Kim, Selvaraj et al. 2006), with 
modifications for the larger size of dog testes. Briefly, the dogs were 
anesthetized and irradiated locally on the testes with a 6 MV linear accelerator 
(10 MeV electrons, dose rate of 300 MU/minute). A 5 cm-diameter cone was 
used to collimate the electron beam to irradiate both testes while minimizing 
exposure of surrounding normal tissue. A fractionated dose of 3 Gy was 
applied to the testes daily for three consecutive days, for a total dose of 9 Gy 
per animal. At 8 weeks after treatment, the testes from these dogs were 
removed for the evaluation of spermatogenesis for the first study. After 
confirming the efficacy of this protocol at depleting male germ cells while 
leaving testicular architecture intact, five other dogs were subjected to focal 
external beam irradiation of their testes by this same method to prepare them 
to be recipients for the SSCT procedure. 
 
Germ cell isolation and culture 
 Mixed germ cells were isolated from donor testes by sequential 
enzymatic digestions, first using collagenase then trypsin (Kim, Selvaraj et al. 
2006). After washing, the cell pellet was resuspended in Dulbeccoʼs Modified 
Eagleʼs Media (DMEM) containing 10 % FBS, 100 mg/ml streptomycin sulfate 
and 100 IU/ml penicillin at a concentration of 67 - 100 million cells per ml. Two 
weeks prior to the transplantation, we isolated mixed germ cells from three 
sets of donor testes. These were maintained in culture. The culture medium 
contained 2 mM L-glutamine, MEM non-essential amino acids, and 20 ng/ml of 
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human Glial Cell Line-Derived Neurotrophic Factor (GDNF, R&D systems Inc., 
Minneapolis, MN) in addition to the components of the collection medium 
noted above. The cultured cells were harvested with 0.25 % Trypsin-EDTA 
and resuspended in the culture media at a concentration of 1.2 million cells 
per ml. Fresh and cultured cell suspensions were kept on ice until the 
transplantation. 
 
Transplantation of mixed tubule cells including SSC into testes 
At 8 weeks after irradiation, five prepubertal dogs were used as 
recipients for the transplantation. The animals were sedated using 
acepromazine (0.02 mg/kg) and butorphanol (0.22 mg/kg), and anesthesia 
was induced with propofol (4 mg/kg) and maintained with isoflurane (1 – 2 %). 
The dogs were placed in right lateral recumbency and the scrotal region was 
prepared for an aseptic procedure. The mixed germ cells were injected into the 
rete testis under the guidance of ultrasound scanning as previously described 
(Honaramooz, Behboodi et al. 2003), with minor modifications. An intravenous 
catheter (22G x 1 inch) was inserted through the caudal pole of the testis into 
the rete testis. Approximately 1 ml of cell suspension was injected into each 
testis until resistance was felt. The spread of the cell suspensions in the testes 
was monitored by ultrasonography from both sagittal and transverse planes.  
 
 Evaluation of sperm production from the recipient testes 
Beginning 7 months after SSCT, manual semen collection was 
attempted from the recipients. However, the animals did not respond (unlike 
intact males from the same facility collected by the same individual during the 
time of this study, data not shown), over a period of 5 months. Blood was 
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collected from the recipients to analyze serum testosterone level by 
radioimmunoassay at Cornellʼs Animal Health Diagnostic Center (Ithaca, NY). 
After repeated failed attempts at manual collection, at 12 months post 
transplantation the recipients were castrated and their testes were collected 
and transported immediately to the laboratory. Epididymal sperm were 
harvested in Tris buffer (0.25 M Tris, 8.8 mM citric acid, 7 mM fructose in 100 
ml of distilled water, pH 6.5) at 37 °C and the motility and number of sperm 
were examined. DNA was extracted from the sperm for genotyping analysis 
and the testes were fixed in Bouinsʼ solution and processed for histologic 
examination. 
 
Genotyping of the recipient sperm 
 The sperm were lysed in sperm lysis buffer (20 mM Tris-HCl, pH 8.0, 20 
mM EDTA, 200 mM NaCl containing 80 mM DTT, 4 % SDS and 2 mg/ml 
proteinase-K; adapted from a user-developed protocol, QIAamp DNA mini kit; 
www1.qiagen.com/literature/protocols/pdf/AQ03.pdf, Qiagen Inc., Valencia, 
CA) at 55 °C for a minimum of 7 hours. Then DNA was extracted with 
phenol/chloroform. Microsatellite analysis was performed to detect the 
presence of sperm derived from the donor in the recipient semen. For this, 
comparisons were made between donor and recipient genomic DNA versus 
DNA extracted from the sperm. Amplification reactions were performed in 
volumes of 25 µl containing 50 ng of template DNA, reaction buffer (10mM 
Tris-HCl, 50 mM KCl, 2 mM MgCl2), 200 µM dNTP (Fisher Scientific, 
Pittsburgh, PA), and 0.5 U of Taq DNA polymerase (Invitrogen, Carlsbad, CA) 
in a Mastercycler gradient PCR machine (Eppendorf, Westbury, NY). The 
protocol was as follows: initial denaturation for 3 min at 94 °C; 94 °C for 15 s, 
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55 °C for 15 s, 72 °C for 30 s for 10 cycles and then 89 °C for 15 s, 55 °C for 
15 s, 72 °C for 30 s for 20 cycles followed by a final extension cycle of 5 min at 
72 °C. One microliter of each PCR product was mixed with 0.2 µl of Genescan 
500 LIZ size standard (Applied Biosystems, Foster City, CA) and 18.8 µl of 
formaldehyde for DNA fragment analysis using an Applied BioSystems 3730xl 
DNA Analyzer. The results were analyzed by GeneMapper Software v3.0 
(Applied Biosystems). 
 An absolute quantitative PCR was performed using an ABI 7500 Fast 
Real-Time PCR system to establish the percentage of donor-derived sperm in 
comparison to a set of standard curves. TaqMan probes carried fluorescent 6-
FAM and VIC as reporter labels at the 5ʼ end for donor and recipient alleles, 
respectively, and a ʻminor groove binder and non-fluorescence quencher 
(MGB/NFQ)ʼ as a quencher at the 3ʼ end. To verify the quantitative accuracy of 
this approach, donor DNA was mixed at specific ratios with that of the recipient 
in preliminary tests (data not shown). This led to the generation of two types of 
standard curve. The first curve was derived for absolute amounts of donor and 
recipient genomic DNA. This served as a baseline against which serial 
dilutions of PCR products from each marker were compared. In addition, 
specific mixtures were created with different ratios of recipient and donor 
genomic DNA (90:10, 85:15, 80:20, and 75:25; recipient:donor). The final 
amplification reaction (10 µl) contained 10 ng of sperm DNA template, 500 nM 
of forward and reverse primers, 150 nM of donor and recipient probes and 1 x 
TaqMan® Fast Universal PCR Master Mix (Applied Biosystems). A two-step 
PCR was used, 3 s at 95 °C and 30 s at 60 °C for 40 cycles following one 
cycle of 20 s at 95 °C. The microsatellite markers and the primers and probe 
for qPCR are listed in Tables 5.1 and 5.2, respectively.  
 124 
 
 125 
Statistical analysis 
Linear regression was performed by JMP 7.0 (SAS Institute Inc., Cary, 
NC) and ANOVA was performed by Kaleida Graph 4.0 (Synergy Software, 
Reading, PA). For statistical hypothesis testing, the P value was set to α = 
0.05. 
 
Results 
Effect of irradiation on male germ cell development 
The effect on male germ cell development of the irradiation protocol of 3 
Gy/day for 3 consecutive days was first tested in the cat (Kim, Selvaraj et al. 
2006), as was the proper timing for transplantation post irradiation. However, 
because different species exhibit different radiosensitivities, we investigated 
the efficacy of this protocol at depleting male germ cells in the dog. We 
irradiated 2 dogs as an initial test and castrated them at 8 weeks after 
treatment. The treated testes showed ≤ 5 % of seminiferous tubules contained 
spermatogonia at the 8 week time point, whereas full spermatogenesis was 
seen in all tubules in age-matched controls (Figure 5.1). There were no visible 
changes in the interstitial cell population or the gross testicular architecture 
between irradiated and untreated testes.  
 
Evaluation of recipient testes and sperm 
 We next irradiated the testes of 5 more dogs to prepare them as 
recipients for SSCT. At 8 weeks post irradiation, transplantation was 
performed into 3 dogs with mixed tubule cells that had been maintained in 
culture for 2 weeks in an effort to expand SSC numbers. As the dogs were  
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Figure 5.1. Cross section of seminiferous tubules from irradiated 
and untreated dog testes. Histological appearance of a treated testis 
8 weeks after irradiation (A) and an age-matched, untreated control 
testis (B). Spermatogonia were seen as the only spermatogenic cells in 
the treated testes (arrowhead in panel A), whereas full 
spermatogenesis was observed in the seminiferous tubules of a 7-
month old control animal. Bar = 100 µm. 
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recovering from anesthesia, they began to show an allergic reaction with 
generalized urticaria and pruritus. The symptoms resolved quickly after I.V. 
injections of diphenhydramine (40 mg/kg) and dexamethasone (2 mg/kg). 
Throughout the study, the testes of these 3 dogs remained uniformly small, 
and repeated attempts at manual semen collection failed between 5-12 
months post transplantation. Therefore, we castrated them at this time. 
Histological sections revealed that >95% of tubules had a Sertoli cell-only 
phenotype (Figure 5.2), with the remaining tubules having some 
spermatogenesis that proved to be completely of recipient origin. Motility of 
epididymal sperm collected from these individuals was uniformly poor, visually 
assessed to be less than 5%.  
 The other 2 dogs were transplanted with fresh mixed tubule cells, in the 
base medium used for initial collection (i.e. without the glutamine, non-
essential amino acids, and GDNF that had been added to our culture 
medium). These dogs had no allergic response, but also showed low libido 
and no interest in urine from a bitch in heat, and did not ejaculate upon 
repeated attempts at manual collection by a trained investigator. Therefore, 
these animals were also castrated at 12 months post-procedure for collection 
of sperm from the epididymides and histological inspection of the testes. The 
number of sperm collected from one recipient was higher than the other, but 
the percentage of motile sperm was similar between these individuals (R1: 1.8 
x 107 sperm and 30% motile, R2: 8.2 x 105 sperm and 40 % motile).  
Despite the lack of normal sexual behavior by any of the 5 dogs, serum 
testosterone concentrations for all 5 were within the normal range (1 – 7 
ng/ml). Furthermore, there were no apparent changes in the histological 
appearance of Leydig cells or Sertoli cells.  
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Figure 5.2. Cross-sections of seminiferous tubules after SSCT. 
Panel A shows both seminiferous tubules that have only Sertoli 
cells, and tubules that show full spermatogenesis (bar = 170 µm). It 
is impossible to discern whether this spermatogenesis is of donor or 
recipient origin by visual inspection in the absence of a protein 
marker specific for the donor (such as a transgene). Panel B is a 
close-up view of panel A (Bar = 30 µm). The arrow and the 
arrowhead in panel B indicate spermatozoa and Sertoli cell, 
respectively.  
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Genotyping of sperm collected from the recipients 
 Six microsatellite markers from the ʻMicrosatellite Multiplex Set-2ʼ 
(Clark, Tsai et al. 2004) were identified as being informative to distinguish the 
donors (D1 and D2) and recipients (R1 and R2) (data not shown.). 
Microsatellite analyses showed that R1 produced sperm derived from D1 SSC, 
by means of showing alleles of both the recipient and the donor (Figure 5.3). 
On the other hand, R2 showed no evidence of alleles representing donor D2 
(data not shown).  
 Having identified donor-derived sperm in the epididymides of R1, we 
quantified the relative percentages of origin by performing real time PCR for 
SNPs that we identified as being able to distinguish between the donor and 
recipient (data not shown). Standard curves of serial dilutions yielded 
consistent and efficient amplifications. The parameters of the assays are 
shown in Table 5.3. Five replicates of the mixture-assay were performed along 
with the standard curve assay and there were no significant differences 
amongst the replicates (ANOVA, p = 0.14 and 0.26, BICFG630J72309 and 
BICF233J57298, respectively). The ratio of donor alleles was calculated from 
each mixture based on the quantities of donor and recipient alleles that were 
obtained against the serial dilution-standard curves. The data set of each 
mixture produced linear regression lines (r2 = 0.93 for both SNP markers) and 
the ratio of donor-derived sperm was predicted by the linear regression. The 
average percentage of donor-derived sperm was 19.5 % from 
BICFG630J72309 and 19.4 % from BICF233J57298 (range 19.0 – 20.1 % and 
17.4 – 21.2 %, BICFG630J72309 and BICF233J57298, respectively). Both 
ranges of values were within a 95 % confidence interval (14.8 – 24.3 % and 15 
– 23.8%, BICFG630J72309 and BICF233J57298, respectively). 
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Figure 5.3. Genotyping plots of microsatellite analysis. There are 
three plots for each marker, with the name of each marker indicated on 
the top of the first plot. The plots were obtained with recipient genomic 
DNA, DNA from sperm produced by the recipient 12 months after 
SSCT, and donor genomic DNA, in the top, middle and bottom rows, 
respectively. The Y-axis indicates the peak heights, the x-axis indicates 
DNA size, and the numbers in the boxes indicate the allele size of each 
peak. The microsatellite profiles for each marker show the presence of 
both recipient and donor alleles in the sperm DNA.  
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Discussion 
The dog is an important animal model to study human diseases 
because its genome and physiology are very similar to those of humans. Dog 
breeds have been developed over varying periods of time so that individuals 
display reproducible morphological, physiological and behavioral traits. This 
selective breeding has carried with it genetic predispositions to a variety of 
diseases that have counterparts to human diseases. Consequently, 
biomedical researchers can use these breeds to identify genes that are linked 
to certain diseases and traits with consequences for human and dog health 
(Khanna, Lindblad-Toh et al. 2006; Lindblad-Toh, Wade et al. 2005). The 
development of transgenesis would greatly enhance the full utilization of the 
dog as a genetic model, by allowing the effects of single gene alterations to be 
evaluated in a known genetic background. However, technical challenges 
imposed by canine reproduction have restricted conventional approaches to 
transgenesis. For example, the extremely dark cytoplasm of canine oocytes 
makes pronuclear injection difficult, and the high lipid content has thus far 
stymied attempts at oocyte or embryo cryopreservation. A few reports have 
been generated from one group about cloning dogs by somatic cell nuclear 
transfer (Jang, Hong et al. 2008; Jang, Kim et al. 2007; Lee, Kim et al. 2005). 
This would provide another mechanism to generate transgenic individuals; 
however, in many respects SSCT provides a technically more accessible 
alternative. A number of studies have shown that SSC can be transduced and 
used in SSCT to generate transgenic animals. This has been performed in 
mice, rats and goats (Honaramooz, Megee et al. 2007; Nagano, Brinster et al. 
2001; Ryu, Orwig et al. 2006). Our study is the first to achieve SSCT in the 
dog, thereby providing an important step toward transgenesis in this species. 
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 SSCT consists of three major parts: recipient preparation, injection of 
donor germ cells and analysis of sperm produced from the recipient. As the 
first part of the current study, we modified an irradiation protocol that we 
previously developed in cats (Kim, Selvaraj et al. 2006). In cats, we observed 
that about 10% of seminiferous tubules contained meiotic cells at 8 weeks 
post irradiation, whereas we observed that < 5 % of seminiferous tubules 
contained spermatogonia in recipient dogs at 8 weeks after the treatment. 
Because of good reduction in endogenous spermatogonia and no apparent 
histological changes in Sertoli cells or Leydig cells in the treated testes, we 
utilized this protocol for our transplantation experiments. However, abnormal 
sexual behaviors (e.g. no interest in urine from bitches in heat, no ejaculation 
upon repeated manual stimulations, and overall low libido) were observed from 
the 5 dogs that were irradiated and assessed for sperm production at 12 
months post-transplantation.  This failure could have been caused by either 
sub-lethal Leydig cell or Sertoli cell damage. It is also possible that too few 
endogenous germ cells remained to maintain normal communications with the 
somatic cell compartments, resulting in a reduction in overall testis function. 
The serum testosterone concentrations (6.35 ± 3.19 ng/ml, mean ± standard 
deviation) were in the normal range of intact male dogs (1.0 – 7.0 ng/ml), 
arguing against a pronounced Leydig cell defect. Yet, it is possible that serum 
testosterone levels experienced spikes into the normal range but did not have 
normal variations. Continual monitoring of testosterone levels was not 
pursued, so the cause of the behavioral deficit remains unclear. Our findings 
suggest that the irradiation protocol should be modified in future attempts to 
promote overall testis function. 
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 An alternative explanation might be that the recipient testes responded 
immunologically after SSCT. However, only the dogs receiving cultured cells 
responded with a visible allergic reaction, suggesting that a medium 
component (likely additional amino acids and/or GDNF) was responsible for 
the difference between the groups. No allergic or inflammatory response was 
seen in the 2 recipients of fresh mixed tubule cells, and the support of donor 
spermatogenesis in 1 of 2 recipients of the fresh cells strongly suggests that 
immune modulation of the recipient is not a strict requirement. In this regard, 
the dog would resemble other domestic animals such as pigs (Honaramooz, 
Megee et al. 2002), goats (Honaramooz, Behboodi et al. 2003; Honaramooz, 
Megee et al. 2007), and bulls (Herrid, Vignarajan et al. 2006).  
 Success in one individual in the current study showed that the 
transplanted SSC were able to support full spermatogenesis, resulting in 
epididymal sperm. In this individual, analyses of 6 microsatellite markers 
known to differ between the donors and recipients all showed mixed alleles. 
Quantitative PCR using TaqMan probes based on SNPs estimated the 
percentage of the donor-derived sperm at 19.5%. Several methods have been 
used to estimate the amount of donor-derived sperm production from recipient 
testes after SSCT. These have included counting progeny (Brinster and 
Avarbock 1994), or quantifying donor cells expressing a visible marker in the 
recipient testes (Dobrinski, Ogawa et al. 1999; Herrid, Vignarajan et al. 2006; 
Honaramooz, Behboodi et al. 2003; Honaramooz, Megee et al. 2002). Even 
though the approaches to quantification have differed, the percentage of 
donor-derived spermatogenesis has tended to fall within a range of 10-35%, 
which is similar to our result. 
 136 
 This study shows for the first time that SSCT can be performed 
successfully in the dog in the absence of any modulation of the recipientʼs 
immune system, and lays a foundation for the production of transgenic dogs 
using SSC that have been modified prior to transplantation.   
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CHAPTER 6 
An alternative approach to canine transgenesis  
using canine embryonic stem cells 
142 
Abstract 
 Research animals have contributed greatly to biomedical research and 
human welfare. Among the species used as research models, the dog has 
been unique for the following reasons: the similarities of their genome and 
physiology to those of humans, and the unique genetic makeup in each dog 
breed that has resulted from artificial selection. Although breed predisposition 
to particular diseases makes finding the responsible genes an attractive 
pursuit, linkage analysis alone is not sufficient to understand roles of single 
genes outside the context of genetic background. Therefore, development of 
transgenesis will enhance the utility of dogs as a genetic model. In this study, 
we attempted to generate transgenic dogs using canine embryonic stem (cES) 
cells. To achieve this, we needed 1) to predict the timing of ovulation for the 
accurate collection and staging of blastocysts, 2) to derive cES cells, 3) to 
manipulate dog blastocysts, and 4) to transfer canine embryos. Because this 
last stage is essential for multiple approaches to transgenesis, and because 
this technique has only been performed successfully a handful of times in the 
world, we emphasized optimizing canine embryo transfer. Female beagles 
aged 1-5 years were either mated with males to serve as embryo donors or 
were used as recipients of embryo transfer. Embryos were collected at days 
14-15 post LH surge and 87.9% of the collected embryos were at blastocyst 
stage. Fresh embryos were transferred to recipient bitches at day 14-15 and 
41.6% of blastocysts implanted and all were born as healthy puppies. To 
derive cES cells, the inner cell mass (ICM) was isolated from blastocysts. 
Although some of these cells developed into ES cell-like colonies, none of 
them was able to be established as ES cell lines. We succeeded in developing 
a methodology to penetrate canine blastocysts. We used this approach to 
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inject putative cES cells from another laboratory and then transferred these 
chimeric embryos into recipients. Although we observed 7 implantation sites 
(out of 8 embryos transferred), all embryos died and were resorbed. Data 
obtained some months later suggested that the ES cell line we used was 
subject to chromosome instability, suggesting a possible cause of embryonic 
mortality. Therefore, in the current study, we did not generate a transgenic dog 
from the cES cell-injected blastocysts. However, we demonstrated that canine 
transgenesis mediated via ES cells is technically feasible based on the high 
success rate of embryo transfer and our ability to manipulate blastocysts.  
 
Introduction 
 Since the first successful transgenic mouse was made by microinjection 
of foreign DNA into embryos in 1980 (Gordon, Scangos et al. 1980), the vast 
majority of transgenic animals have been mice. The utility of these animals as 
disease and research models has been tremendous. Over time, transgenesis 
has been applied to other species such as rats, rabbits, goats, pigs and cows, 
and these animals are being widely used in the areas of agriculture, medicine 
and industry (Margawati 2003). Transgenesis in farm animals could quickly 
lead to the establishment of breeds with a particular trait. For example, 
transgenic cows might produce more milk, or milk with less lactose or 
cholesterol, pigs and cattle could produce more lean meat, and transgenic 
sheep could grow more wool. For medical applications, pigs might provide 
organs for xenotransplantation of human hearts, livers or kidneys. In addition, 
milk-producing farm animals have been generated that produce particular 
human proteins such as insulin, growth hormone and anti-coagulant factors in 
their milk (Maga, Shoemaker et al. 2006; Niemann and Kues 2003). Although 
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these animals play a critical role in biomedical research and human medicine, 
they have limitations in serving as models of human disease. Because there 
are significant differences in the genetic and physiological profiles of humans 
and mice, the development of appropriate mouse models for a large number of 
critical human diseases has been difficult. Agricultural species such as sheep 
and cows also have dramatically different physiologies. Therefore, the 
development of other mammalian models with a more similar genome and 
physiology to humans is highly desirable. In this regard, the dog has been an 
important animal model to study human diseases because their genome and 
physiology is much more similar to humans. Moreover, recently completed 
sequencing of the dog genome is facilitating investigations of diseases 
occurring in both humans and dogs. Over 360 naturally-occurring canine 
genetic diseases have been shown to have counterparts in humans, including 
forms of cancer, blindness, deafness and congenital heart disease (Sutter and 
Ostrander 2004). Moreover, several diseases have been shown to involve the 
same gene in both species, such as muscular dystrophy and bleeding 
disorders (Ostrander and Wayne 2005).  
 More than 400 different dog breeds have been established by artificial 
selection, which has resulted in not only unique morphological and behavioral 
characteristics but also susceptibility to certain disease for each breed (Sutter 
and Ostrander 2004). This predisposition allows identification of the gene(s) 
responsible for a particular disease. Although, linkage analysis has verified a 
number of genes related to specific diseases (Ostrander and Wayne 2005; 
Tsai, Clark et al. 2007), this analysis will not be able to fully explain the role of 
that single gene in a pathological condition. Therefore, transgenic dogs should 
be available for the full utilization of this model. However, limitations in our 
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understanding of dog reproduction and our ability to manipulate canine germ 
cells and embryos have prevented the full utilization of the dog as a genomic 
model. DNA microinjection, retrovirus- and embryonic stem (ES) cell- 
mediated gene transfer are conventional methods to generate transgenic 
animals. However, application of these methods to generate transgenic dogs 
has been hampered by difficulty in microinjection due to the highly opaque 
canine zygote, the current inability to manipulate canine early embryos, and 
the previous unavailability of canine ES cells. Therefore, we attempted to 
derive ES cells as a means to produce transgenic dogs. 
 ES cells are derived from inner cell mass (ICM) of blastocysts. They are 
pluripotent and can maintain an undifferentiated status in vitro in defined 
culture conditions. The first well-characterized ES cells were derived from 
mouse preimplantation embryos (Evans and Kaufman 1981; Martin 1981). 
About two decades later, primate ES cells (Thomson, Kalishman et al. 1995) 
were derived as well as human cell lines (Thomson, Itskovitz-Eldor et al. 
1998). Because ES cells can differentiate into multiple cell types under 
different conditions, they can potentially be an important resource for treating 
diseases (Kiessling and Anderson 2006). The following traits are thought to 
characterize ES cells: mRNA and protein expression of stem cell markers 
such as Oct3/4, stage-specific embryonic antigen (SSEA)-3, SSEA-4, Tumor 
rejection antigens (TRA), and Nanog; alkaline phosphatase activity; ability to 
differentiate into cells from all three germ layers (endoderm, mesoderm, and 
ectoderm); differentiation into a specific cell lineage; generation of teratoma 
and chimeric animals (Conley, Young et al. 2004; Eiges, Schuldiner et al. 
2001; Longo, Bygrave et al. 1997; Thomson, Itskovitz-Eldor et al. 1998; 
Thomson, Kalishman et al. 1995). The ability of ES cells to integrate into the 
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ICM of blastocysts, thereby generating chimeras, facilitates transgenesis using 
these cells if their genomes have been manipulated (Gossler, Doetschman et 
al. 1986). A number of transgenic mice have been generated by this approach 
including knockout mice, which are the most popular animal models for 
studying the functions of specific genes. Even though there have been a few 
reports about canine embryonic stem cell-like cells (Hayes, Fagerlie et al. 
2008; Shingo Hatoya, Ryuzo Torii et al. 2006), the reported cell lines have not 
shown the complete set of required characteristics. Notably, none of these cell 
lines have contributed to the germ line. Very recently, after the current studies 
were completed and during the writing of this dissertation, a report has been 
published that describes a cES cell line with the ability to form teratomas 
(Vaags, Rosic-Kablar et al. 2008). The existence of this cell line makes the 
studies described below of even higher relevance, as our development of 
these technologies might enable that cell line to be used to generate 
transgenic dogs. 
ES cell-mediated transgenesis also requires a set of skills including 
blastocyst manipulation (for the injection of ES cells into the embryo), and 
embryo transfer. Although embryo transfer is a common technique for some 
species including laboratory rodents and agricultural animals, there are only a 
few reports of successful canine embryo transfer leading to production of 
normal offspring (Lee, Kim et al. 2005; Tsutsui, Hori et al. 2006; Tsutsui, Hori 
et al. 2001b; Tsutsui, Hori et al. 2001c), primarily due to a lack of 
understanding of the reproductive physiology of female dogs. For example, 
canids are unique in ovulating a primary oocyte. 
Previous studies demonstrated that early embryos, at the 2-cell to 
blastocyst stage, are suitable for transfer (Hori, Hagiuda et al. 2005; Tsutsui, 
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Hori et al. 2006; Tsutsui, Hori et al. 2001a; Tsutsui, Hori et al. 2001c). 
Recently, dogs cloned by the somatic-cell nuclear transfer method have been 
reported (Jang, Hong et al. 2008; Jang, Kim et al. 2007; Lee, Kim et al. 2005), 
and the initial report claimed that the transfer of very early-stage embryos (4 hr 
after oocyte activation) is crucial in successful embryo transfer for dogs (Lee, 
Kim et al. 2005). However, in our study, we focused on blastocyst-stage cells 
for embryo transfer in the dog because the blastocyst would be the optimal 
stage to induce transgenesis by injection of cES.  
 Canine estrus occurs in a highly random pattern with the inter-estrous 
interval varying in bitches from 16 to 56 weeks (Bouchard, Youngquist et al. 
1991; Christie and Bell 1971). This has significantly hindered canine 
reproductive research because of the costs associated with maintaining the 
very large numbers of bitches needed. In this regard, artificial estrus induction 
would be beneficial to generate synchronized donor and recipient bitches. A 
number of hormonal methods to induce estrus in bitches have been reported, 
including exogenous gonadotropins (Cain, Cain et al. 1988; Kusuma and 
Tainturier 1993; Shille, Thatcher et al. 1984; Vanderlip, Wing et al. 1987), 
dopamine agonists (Beijerink, Dieleman et al. 2003; Rota, Mollo et al. 2003; 
Spattini, Borghi et al. 2007; Zoldag, Fekete et al. 2001), and GnRH analogs 
(Cain, Cain et al. 1988; Inaba, Tani et al. 1998; Vanderlip, Wing et al. 1987; 
Volkmann, Kutzler et al. 2006a). An alternative, indirect method has also been 
used. In this approach, exogenous androgens (e.g. mibolerone) are applied in 
late anestrus, and then are withdrawn. This protocol is designed to release 
inhibition and allow a treated cohort to come into estrus with greater synchrony 
than if left untreated. However, the efficacy of these methods is highly 
variable. To avoid the need for synchronization, frozen embryos can be used 
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for more efficient embryo transfer. However, successful cryopreservation of 
canine embryos has yet to be reported, largely because of the high lipid 
content in canine oocytes/embryos.  
 In this study we investigated the derivation of canine ES cells, the 
synchronization of estrus, the cryopreservation and transfer of embryos, and 
the manipulation of canine blastocysts.  
 
 
Materials and Methods 
 
Reagents were purchased from Invitrogen, Inc. (Carlsbad, CA) unless 
otherwise stated. 
  
Animals 
Female dogs, aged 1-5 years, were purchased from Marshall 
BioResources (North Rose, NY). Three 5-year-old Labrador retriever sires 
were used for semen collection. All experimental protocols were reviewed and 
approved by the Institutional Animal Care and Use Committee of Cornell 
University.   
 
Timing of ovulation and artificial insemination 
Bitches were purchased in late anestrus as determined by their 
reproductive histories and serum progesterone levels, and were monitored 
every other day for signs of proestrus including vulvar swelling and 
seroganguineous vaginal discharge. Once one of these signs was observed, 
blood was collected for determination of serum progesterone (P4) levels by 
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ChemiLuminescent Immunoassay (CLIA, Cornell Animal Diganostic Center, 
Ithaca, NY), every other day until P4 reached peripheral concentrations higher 
than 0.5 ng/ml. At that time it was collected every day until the concentration 
was over 5.0 ng/ml, at which point it was again collected every other day until 
passing 15 ng/ml. In addition, vaginal smears were obtained every other day 
until the first day of mating. Day 0 (the day of LH surge) was identified by a 
serum P4 level of between 1.5– 2.5 ng/ml. Artificial insemination was 
performed on day 2, 4 and 6 with fresh semen that was collected from one of 
the three breeding sires in our kennel. The number and motility of sperm were 
briefly examined using light microscopy to ensure semen quality. 
 
Synchronization of estrus in bitches 
To synchronize the estrous cycles of recipients and donors, mibolerone 
(100 mg/ml, RoadRunner Pharmacy, Phoenix, AZ) or Ovuplant (2.1 mg of 
Deslorelin/implant) were used as shown in Table 6.1. Mibolerone was 
administered daily for 2–4 weeks according to the recommendations for 
Cheque-Drops, the commercial mibolerone product that is currently 
unavailable in the United States. Ovuplant was inserted into the vulvar mucosa 
following local anesthesia, achieved first with with lidocaine HCL jelly, 2% 
(Alcorn, INC, Buffalo Grove, IL), followed by 0.2 ml of injectible Lidocaine. The 
implant was removed at 2–3 days post LH surge by making a small incision 
and scraping out the implant with sterile cotton swabs following local 
anesthesia as above. These methods follow the protocol of Kutzler (Kutzler 
2005).  
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Collection of blastocysts   
On day 14-15, the uterine horns and oviducts were removed from the donors 
via ovariohysterectomy and then immediately transported to the laboratory in a 
warm container (~37 °C). The uterus was washed with warm sterile PBS 
(phosphate buffered saline, pH 7.4) and excess blood was blotted with sterile 
gauze. The embryos were flushed from each horn with 10 ml of flushing media 
containing DMEM (Dulbeccoʼs Modified Eagle Medium), with 15% FBS (fetal 
bovine serum), and 100 IU/ml of penicillin and 100 µg/ml of streptomycin, 
through a 20 gauge needle inserted at the tip of uterine horns. The flushed 
embryos were recovered in complete TCM, which was TCM-199 
supplemented with 15% FBS, penicillin and streptomycin, at 39 °C, in a 5 % 
CO2 incubator until they were transferred or processed for ES cell derivation.  
  
Feeder cell derivation  
 Primary canine embryonic fibroblasts (CEF) or mouse embryonic 
fibroblasts (MEF) were used as feeder cells. Dog and mouse embryos were 
collected at 30 and 14 gestation days, respectively, to derive the feeder cells. 
The derivation protocol was applied similarly to CEF and MEF. Briefly, the 
embryos were removed from embryonic sacs inside uterine horns under an 
aseptic hood. Visceral tissue was removed from the embryos and the 
remaining tissue was washed three times with 10 ml PBS. The cleaned 
embryos were minced into 3-4 mm-sized pieces, followed by addition of 2 ml 
of trypsin-EDTA solution and additional mincing. Another 5 ml of trypsin 
solution was added to the plate and the suspension was placed in a 37 °C 
incubator for 20-30 min. After the trypsin incubation, the mixture was pipetted 
vigorously up and down until having a relatively uniform, thick consistency, at 
which time DMEM supplemented with 10% FBS, penicillin and streptomycin 
was added. 
 151 
 
 
 
Table 6.1. Embryo recovery and uses  
Day of embryo recovery  
Donor ID after LH surge after mating 
no. CL 
no. embryo 
recovered 
(developmental 
stage*) 
use 
4199863 14   3 2 (B) 
4477162 15  5 4 (B), 1 (H) 
4511140 - 10 6 2 (morulae), 4 (B) 
4352661 - 10 8 8 (B) 
4511573 14  7 2 (B), 4 (deg) 
Fresh 
embryo 
transfer 
4168224 14  5 1 (ExB), 3 (B), 1 (EB) 
4611225 14  5 2 (H), 3 (B) 
4260597 14  9 1 (H), 7 (ExB) 
4212916 14  9 6 (ExB), 2 (B) 
4295889 14  7 4 (ExB), 3 (B) 
4295731 14  8 2 (ExB), 2 (B), 2 (EB) 
4550099 14  7 3 (B), 3 (EB), 1 (deg) 
4791754 14   9 9 (B) 
Frozen 
embryo 
transfer 
5037867 14  8 6 (B), 1 (deg) 
4983424 14  8 4 (EB) 
4949552 14  6 6 (B) 
cESC 
injected-
embryo 
transfer 
 
*: EB (Early blastocyst), B (Blastocyst), ExB (Expanded blastocyst), H 
(Hatched embryo), deg (degenerated) 
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5ml volumes were placed into a T75 flask containing 10 ml of the DMEM and 
incubated in a 37 °C tissue culture incubator overnight. The following day, the 
spent media was replaced and the cells were cultured until at least 90% 
confluent. The cells were harvested with a trypsin solution, and then were 
frozen with DMEM containing with 20% DMSO and 20% FBS and kept in LN2. 
When needed, the cells were thawed and expanded over two passages prior 
to irradiation at 5500 rad for mitotic inactivation. 
 
ES cell derivation 
  The irradiated feeder cells were plated at 0.75 x105 cells/ml. The 
following day, blastocysts were collected from female dogs, the embryos were 
placed in the complete TCM on a 38.5 °C heated stage, and then the zona 
pellucida and trophoblast cells were removed by mechanical dissection. The 
isolated ICM were placed on either a CEF or MEF feeder layer in ESC 
medium, containing Dulbecco's modified Eagle's medium (DMEM)/F12 
medium (DF12) containing 15% serum replacer, 0.1 mM nonessential amino 
acids, 1 mM L-Glutamine, and 4 ng/ml basic fibroblast growth factor (bFGF). 
The cells were monitored daily until the colony was deemed ready for first 
passage (usually 5-7 days), which was performed mechanically. 
 
Manipulation and transfer of blastocysts 
 Putative canine ES cells, FhDo7, were obtained from Dr. Beverly Torok-
Storb at the Fred Hutchinson Cancer Research Center (Seattle, WA) for 
microinjection into canine blastocysts. The cells were maintained in the same 
fashion as described in their manuscript (Hayes, Fagerlie et al. 2008). The 
FhDo7 cells expressed enhanced green fluorescence protein (eGFP) as a 
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result of transduction with a lentiviral vector containing the appropriate 
sequence. Therefore, we were able to use fluorescence to select ES cells from 
the mixture of the ES cells and mouse feeder cells after trypsinization with 
TrypLE.  Three 7 µl droplets of complete TCM for blastocysts, one 7 µl droplet 
of cESC media for FhDo7 cells, one 3 µl droplet of 0.25% pronase, and one 10 
µl droplet of complete TCM for rinsing tips were placed in the center of a 35 
mm petri dish. The dish was flooded with mineral oil and maintained on a 
heated stage of an inverted microscope (Eclipse TE2000-U microscope, 
Nikon, Melville, NY) equipped with micromanipulators, and holding and micro-
injection pipettes (Eppendorf, Westbury, NY). Flushed blastocysts were placed 
in the complete TCM at 37 °C incubator with 5% CO2 in air until microinjection 
and then each blastocyst was transferred to the 7 µl-droplet of complete TCM. 
Green FhDo7 cells were selected with the transfer pipette from a mixture of 
MEF and the cells in the cESC droplet, and then moved to the droplet 
containing the blastocyst. The ES transfer pipette was filled with a small 
volume of 0.25% pronase taken from the pronase droplet. A hole was made in 
the zona pellucida by slowly releasing the pronase up against the wall of the 
zona pellucida until the tip could penetrate the hardened extracellular matrix. 
After removing the tip, it was placed in the rinsing droplet and washed 
thoroughly, prior to being used to pick up the FhDo7 cells. The tip was 
returned to the hole and the cES cells were injected into the blastocyst. The 
cES cell-injected and cESC media-injected (sham-control) blastocysts were 
kept in the complete TCM (+/- sodium butyrate depending on the experiment), 
and transferred into synchronized recipients immediately after the 
manipulations were finished.  
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 For embryo transfer, bitches synchronized with the donors were used. 
They were anesthetized, clipped, scrubbed, and opened with a small ventral 
midline incision in the cranial abdomen. The uterus was visualized and 
inspected. A hole was made at the tip of the left uterine horn by a 16-gauge 
needle through which the manipulated fresh, or intact fresh or frozen embryos 
were transferred. A P200 Pipetteman with a large orifice, “cell-saver” tip was 
used to transfer the embryos in 70 µl of the recovery media. A small suture 
was placed to mark the site of injection, and then the abdomen was closed 
using a standard 3-layer technique. Pregnancy was examined by 
ultrasonography on days 28–30 after the LH surge of the recipient. To time 
parturition, bitches were monitored for signs of distress, pain, inappetence, 
lactation, and changes in P4 and body temperature beginning on day 63. The 
pups were delivered by Cesarean section on day 65 after the LH surge. 
 
Vitrifying and thawing blastocysts 
 Two methods were compared for vitrification of canine embryos. TCM 
199 containing 10 % FBS, penicillin and streptomycin was used as a base 
medium for both. For treatment A, embryos were incubated in the base 
medium for 1 min and then moved to vitrification solution [7.5 % (v/v) ethylene 
glycol (Sigma-Aldrich, St. Louis, MO) and 7.5 % (v/v) DMSO (Sigma-Aldrich) in 
the base medium] for 3 min. The embryos were transferred to 17 % ethylene 
glycol and 17 % DMSO and 0.4 M Sucrose (Sigma-Aldrich) in the base 
medium and immediately loaded onto an EM-Grid (Ted Palla, Inc., Redding, 
CA). The embryos loaded on EM-Grids were plunged into LN2 and kept in 
cryovials.  For treatment B, embryos were pre-incubated in the base medium 
containing 7.5 µg/ml cytochalasin B (Sigma-Aldrich) and 0.1 mM ascorbate 
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(Sigma-Aldrich) for 15 min and then processed as for treatment A. The 
embryos were kept in LN2 until thawing before transfer. 
 To thaw the embryos, the EM-Grids were held in the air for 2 sec at RT 
and then immersed into 5 ml of 0.5 M sucrose in the base medium at 37 °C for 
1 min. Cryoprotectant was removed by incubating the embryos in 5 ml of 0.25 
M, 0.125 M, and 0 M sucrose in the base medium for 5 min successively. The 
embryos were immediately transferred into recipients.  
 
Statistical analysis 
ANOVA was performed by Kaleida Graph 4.0 (Synergy Software, 
Reading, PA). For statistical hypothesis testing, the P value was set to α = 
0.05. 
 
Results 
Synchronization of estrus 
A total of 62 bitches were used for the studies in this chapter, which 
consisted of 4 different batches during a period of 3 years. Thirty-nine bitches 
were allowed to have natural onset of estrus and 10 of these were 
synchronized (25.6%). Eighteen bitches were treated with mibolerone resulting 
in synchronization of 6 bitches (33.3 %), whereas 5 bitches were treated with 
Ovuplant and 4 of them were synchronized (80.0 %). However, 50% of the 
embryos collected from Ovuplant-treated bitches were degenerated whereas 
no apparent defects were found in the embryos from mibolerone-treated 
bitches.  
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Embryo recovery  
Table 6.1 shows the results of embryo recovery and their uses for 
embryo transfer experiments and Figure 6.1 shows the embryos collected on 
days 14-15. The time of ovulation (D0) was indicated by serum progesterone 
concentration except for two bitches, whose signs of cycling were not detected 
until after D0. On day 14–15, 90.0 % (99 embryos/110 corpus lutea) of the 
embryos were recovered from both uterine horns of 17 donor bitches and 87.9 
% (87/99) of the collected embryos were at blastocyst stage. The embryos 
from mibolerone treated and untreated bitches didnʼt show any apparent 
differences regarding number or developmental stage (p=0.46). Some of them 
were at early blastocyst stage shown in Figure 6.1.A. but after 2-6 hours in 
culture, they expanded to regular blastocysts as shown in Figure 6.1.B. 
 
Figure 6.1. Canine embryos collected at 14 days post LH surge.  
A. early blastocyst; B. blastocyst; C. expanding blastocyst and D. 
degenerated embryo. 
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ES cell derivation 
 Fifty-four blastocysts collected from 8 bitches were plated on either 
primary canine embryonic fibroblast (CEF) or mouse embryonic fibroblast 
(MEF) feeder layers. About 30% of ICM expanded as round, dark-brown cell 
clumps, with any attached trophoblast cells growing out in a flattened sheet 
atop the feeder cells (Figure 6.2). At 5-7 days of culture, the expanded group 
of cells from ICM was first passaged. After passage, some of the surviving 
ICM cells maintained the morphology of putative ES cell colonies whereas the 
rest of them began to differentiate at the outer edge of the colonies. Although a 
small number of colonies were maintained in culture over three passages, 
eventually all of them differentiated before they could be characterized for ES 
cell markers, and no stable canine ES cell lines were established. 
 
 
Figure 6.2. Expanded ICM on MEF in hESC culture media on day 4 (A, 
x100) and day 6 (B, x200). The dark brown colony in the middle of the 
images was derived from ICM and trophoblast cells are visible as a flat 
outgrowth around the group of ICM cells. 
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Embryo transfer 
 Table 6.2 shows the results of a series of embryo transfer experiments. 
When transferring fresh embryos, the day for the transfer was either day 14 or 
15 for both donors and recipients. All four transfers on days 14-15 were 
successful in terms of observing embryo implantation and in terms of 
production of live offspring on day 65. The yield of 41.6 % (5 feti out of 12 
transferred embryos) was identical to the number of implantation sites 
observed by ultrasonography, suggesting that there were no abortions or other 
developmental difficulties post-implantation. All puppies were born healthy and 
maintained normal health status until they were adopted. In the case of the 
first two offspring, these animals have maintained good health for a period of 
close to 3 years. Contact has not been maintained with the owners of the other 
3 adopted embryo transfer puppies. All embryos used for vitrification were 
collected on day 14 from bitches that had estrus occur naturally. Frozen 
embryos all had normal appearance immediately after thawing;, however, 
none of frozen embryos transferred resulted in successful implantation. 
 In experiments in which blastocysts were injected with putative canine 
ES cells, again no live births were observed. On day 30 post LH surge, 
ultrasound was performed to detect pregnancy, but neither of the recipients 
had a live fetus. However, one of the recipients (ID#4773071) had 7 
embryonic resorption sites in both uterine horns (4 on one side and 3 on the 
other side), whereas the other recipient did not have any evidence of 
implantation. The embryos that did not implant were transferred after 
incubation with sodium butyrate.  
 
 
 159 
 
 
 
Table 6.2. Results of embryo transfer 
  
Day of 
transfer  
 
Donor ID Recipient ID after LH 
surge 
no. 
embryo 
implanted  
no.  
pup 
Fresh 
ET 4199863
M 3328350M 15 2 1 
 4477162M 3555429N 14 4 1 
 
4511140N,  
4352661N 4335490
N - 4 2 
 4511573D 4513126D 14 2 1 
Frozen 
ET 4168224, 4791754 4454464 14 
2 (A)  
2 (B) 0 
 4611225, 4550099 4652649 14 
4 (A)  
3 (B) 0 
 
4295731, 4550099, 
4260597, 4791754, 
4295889 
4625153 14 10 (A)  5 (B) 0 
 4212916 4331192 14 6 (A) 0 
  4295889, 4295731 4460162 14 
3 (A)  
2 (B) 0 
5037867, 4983424 4773071 14 5 (E)  3 (S) 0 cESC injected 
ET 4949552* 5084121 14 4 (E) 2 (S) 0 
 
M: Mibolerone treated, N: No treatment, D: Deslorelin treated, A: frozen in 
VSA, B: frozen in VSB, *: embryos treated with 0.2mM sodium butyrate prior to 
transfer, E: cESC injected, S: sham injected 
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Figure 6.3. GFP expressed-cESC Injected blastocysts. Panels A, B, and 
C show the same blastocyst immediately after injection with green cESCs 
(bright field, green florescence and merged pictures, respectively). Panel D 
shows 8 embryos injected with either medium only (3 embryos, arrowheads) 
or green cES cells (5 blastocysts) prior to transfer.  
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Discussion 
 The development of biomedical research has been greatly advanced by 
the use of different species of research animals.  Of these, the dog has been a 
unique research model for human medicine because its genome and 
physiology are similar to those of humans (Joy, Basak et al. 2006). Almost 400 
different breeds of dogs have been established over a short period of time, 
yielding particular traits that are unique to each breed. As a result of this 
selection process, each breed has developed genetic predispositions to 
particular diseases and behavioral and morphological characteristics. 
Numerous laboratories are using the canine model to identify the genes linked 
to these diseases (Ostrander and Wayne 2005). However, linkage analysis 
cannot demonstrate how a gene is involved at the cellular level or is 
responsible for the disease pathologically. By providing a method to test the 
action of a single gene in a different genetic background, by providing the 
ability to mark specific cells and tissues, and by providing the ability to delete 
specific genes, transgenesis would allow the full utilization of this biomedical 
model.    
 There have been a small number of reports about derivation of cESC 
(Hatoya, Torii et al. 2006; Hayes, Fagerlie et al. 2008; Schneider, Adler et al. 
2007; Vaags, Rosic-Kablar et al. 2008). Among the studies, Hayes et al. and 
Vaags et al. showed their cell lines have the most potential to be true ES cells, 
especially the cESC from the latter group, which were able to form teratomas. 
However, as of yet, there are no reports about chimeric dogs being generated 
with cESC. Our attempts to derive cESCs were part of our effort to develop 
transgenesis in the dog, because there were no reports of cESCs at the time. 
We tried both immuno- and mechanical dissection of blastocysts to isolate the 
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ICM and found that the immunodissection with anti-bovine trophectoderm was 
not suitable for canine blastocysts because of the weak cross-activity of the 
antibody (data not shown). Mechanical dissection of blastocysts was preferred 
for isolating ICM as well as for subculture of primitive ES colonies, which is in 
agreement with the findings of other groups using cells from dogs (Hayes, 
Fagerlie et al. 2008; Vaags, Rosic-Kablar et al. 2008) as well as human cells 
(Thomson, Itskovitz-Eldor et al. 1998). The proliferative cell clusters derived 
from ICM initially maintained their ES cell-like appearance; however, they lost 
their undifferentiated status at an early passage, which prevented us from 
characterizing the cells. Although the derivation of cES cells was not 
successful in our laboratory, these attempts provided valuable information and 
experience with female reproductive physiology and early canine embryo 
development. Thus, these efforts laid the foundation for our successful canine 
blastocyst transfer, which itself we hope is a step toward canine transgenesis 
mediated by ES cells.   
 The reproductive physiology of a bitch is different from almost all other 
mammals. Oocytes are ovulated at the germinal vesicle stage and both stages 
of meiosis occur in the oviduct. Moreover, it has been shown that the onset of 
estrus is not accurately related to the time of ovulation. These unique 
characteristics have been obstacles in the development of assisted 
reproductive techniques in the dog. For example, more sophisticated oocyte 
culture conditions are required for in vitro maturation and in vitro fertilization. In 
addition, it is very difficult to time ovulation and synchronize multiple females 
to perform embryo transfer. However, we used a combination of vaginal 
cytology and serum P4 profiles to predict the retrieval date of blastocysts in 
the current study and these parameters were highly accurate (92.2 % of 
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healthy embryos was blastocysts). For our embryo transfer studies, the 
parturition date was calculated with the same parameters, as well as fetal 
measurements taken by transabdominal ultrasonography on D28-30. All of the 
puppies were born by Caesarian section on D65. Therefore, the 
measurements of P4 and vaginal cytology are reliable methods to predict the 
ovulation timing of a donor and to make sure that a recipient is ready with an 
appropriately prepared uterine environment. Additional monitoring with 
transabdominal ultrasonography and several observations of the pregnant 
bitches were together highly effective to choose an appropriate day for 
caesarian section.  
In order to reduce the number of dogs needed, and to perform embryo 
transfer more effectively with less labor and expense, we investigated two 
different aspects of assisted reproduction. The first was estrous 
synchronization, and the second was embryo cryopreservation. For the first 
approach, we used either mibolerone or deslorelin in an attempt to induce 
synchronized estrus in the bitches. Our experimental design was based on 
previous reports of timing of estrus post-treatment (Kutzler 2005; Volkmann, 
Kutzler et al. 2006b), and did not seek to determine the potential effects of 
these treatments on embryo quality. Mibolerone is an androgenic steroid 
approved for estrus suppression in the dog. According to the manufacturer, it 
can take 7-200 days for the bitch to resume the next cycle after mibolerone 
withdrawal. However, our co-investigator (Dr. Vicki M-W, James A. Baker 
Institute For Animal Health, Cornell University, Ithaca) used this drug in clinical 
practice, administering it daily to achieve at least a 6-month interval from the 
last estrus, to synchronize bitches at the late anestrous phase. After 
completing such a regimen, she observed that most bitches exhibited 
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proestrus approximately 2 weeks after mibolerone withdrawal. Similarly in this 
study, daily mibolerone treatment was begun in all bitches during anestrus and 
was maintained to synchronize them in late anestrous. All bitches in a housing 
group were then withdrawn on the same day. Estrous synchronization in each 
housing group was achieved through the "dormitory effect," wherein bitches in 
proestrus or estrus stimulate estrus induction in late anestrus bitches that are 
housed together (Concannon 1993). Another drug, deslorelin, has been 
studied for its efficacy in the synchronization of bitches (Kutzler 2005; 
Volkmann, Kutzler et al. 2006a; Volkmann, Kutzler et al. 2006b). Deslorelin is 
a GnRH analog, which stimulates the release of LH to grow follicles and 
induce ovulation. About 33 % and 80 % of dogs were synchronized among the 
dogs treated with mibolerone and deslorelin, respectively. However, about 50 
% of embryos collected from the deslorelin-treated bitches were degenerated. 
These data suggested an unfavorable trade-off between synchronization 
success and embryo quality.  
As an alternative to synchronization of bitches, cryopreservation of 
embryos can be used. This has never been reported in the dog. Therefore, we 
tested vitrification methods, which involve the immediate transition from a 
liquid into a glass-like phase, thereby inhibiting the formation of ice-crystals. 
This method has been widely used for gamete preservation (Beebe, Cameron 
et al. 2005; dela Pena, Takahashi et al. 2001; Menezo 2004; Wusteman, 
Robinson et al. 2004). However, the vitrification protocols used in this study 
did not preserve dog blastocysts successfully. All frozen-thawed blastocysts 
failed to implant or develop to fetus after transfer. 
While embryo transfer techniques were being established in our laboratory, 
putative cES cells were being derived in the laboratory of Dr. Beverly Torok-
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Storb at the Fred Hutchinson Cancer Research Center (Hayes, Fagerlie et al. 
2008). Although their cell lines showed various essential characteristics that 
define ESC—including differentiating into three different germ layers and 
expression of appropriate nucleic acid and antigenic markers—that group was 
not able to test the ability of their cells to contribute to the germline because of 
a lack of experience in canine reproductive physiology. As described above, 
the early canine embryo is surrounded by a zona pellucida that is in some way 
different from most other mammals, in that it is tougher and more elastic such 
that it cannot be penetrated by conventional methods including piezo drills or 
laser drills (Figure 6.4.B and data not shown). In our preliminary study, we 
observed that canine blastocysts can be penetrated by trickling pronase on a 
single point of the zona pellucida to create a small opening that can be used 
as a portal through which cells can be injected (Figure 6.4.C-E). These 
embryos maintained normal shape and appearance after the hole was made. 
This approach was needed because exposure to pronase in the droplet itself 
resulted in blastocyst death (data not shown). We applied this method to 
generate chimeric embryos in the current study.  Although none of our cES-or 
sham-injected blastocysts developed past implantation, we observed 7 
implantation sites out of 8 transferred embryos (3 sham and 5 cES injected) in 
the first trial. In that trial, inexperience resulted in a lengthy time to manipulate 
all 8 embryos, which resulted in a 9-hour interval between the flushing and the 
transfer. Considering that our successful transfers had a maximum 3-hour 
interval, we predicted that the long time spent in a non-ideal environment 
might have affected the fitness of embryos. Therefore, for the second trial, two 
major changes were applied: experience allowed us to manipulate the 6 
embryos in 3 hours to eliminate the time problem, and the manipulated  
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Figure 6.4. Canine blastocysts being penetrated for the injection of ES 
cells. Panel A shows a canine blastocyst collected on day 14, being held by 
a vacuum-operated holding tip on the left side of the panel. The zona 
pellucida surrounding the blastocyst was too elastic to be penetrated. A 
transfer tip can deform the embryo from one side to the other side where the 
holding tip is shown in panel B, and then the zona and the embryo retain 
their original shape. The same embryo was manipulated and penetrated by 
the transfer tip by gently applying 0.25% pronase on a single point of the 
zona pellucida. After washing the tip, the transfer tip could slowly be inserted 
into blastocoele as seen in panels C, D, and E. This blastocyst was 
approximately 400 µm in diameter.  
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embryos were placed in culture medium containing 0.2 mM sodium butyrate in 
an effort to improve the efficiency of transgenesis. This treatment resulted in 
better efficiency with mouse ES cells (personal communication, Dr. Carol 
Ware, University of Washington, Seattle, WA). However, there were no 
implantation sites found from this trial, suggesting either that time was not the 
major problem with this approach, or that sodium butyrate was not tolerated by 
the canine embryos, or that a different problem specific to this single trial was 
encountered.  
In this study, we showed that canine blastocysts can be harvested and 
transferred with high yield, which differs with a previous report (Lee, Kim et al. 
2005). In addition, we obtained favorable success rates with fresh embryo 
transfer in comparison with other reports of transfer at the morula-blastocyst 
stage. In addition, we obtained valuable comparative data on embryo quality 
using different synchronization regimens, and valuable negative data on 
canine blastocyst cryopreservation. Even though this project did not proceed 
further to result in chimeric offspring, we established significant technical 
progress toward the future generation of transgenic dogs. 
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Chapter 7 
Final discussions and Future directions 
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This study explored the potentials of spermatogonial stem cells for the 
preservation of male genetic information and for the development of  
transgenesis in the cat and dog, via the technologies of testis xenografting and 
spermatogonial stem cell transplantation (SSCT).  
 
Lessons learned from studying testis xenografting 
 Testis xenografting was first reported in 2002, using testis tissue from 
mice, pigs and goats (Honaramooz, Snedaker et al. 2002). Since the first 
report, different species were used as donors including cattle (Oatley, Reeves 
et al. 2005; Rathi, Honaramooz et al. 2005), rabbits (Shinohara, Inoue et al. 
2002), cats (Snedaker, Honaramooz et al. 2004), humans (Schlatt, 
Honaramooz et al. 2005), and horses (Rathi, Honaramooz et al. 2006). 
Although most of these studies showed that xenografts could produce sperm 
when the donor testis tissue was obtained from young animals such as 
neonatal mice, pigs, cows or primates, a small number of studies showed that 
adult testicular tissue degenerated in the host mice (Rathi, Honaramooz et al. 
2006). An additional study compared multiple ages of donors for the success 
of bovine testis xenografting (Schmidt, de Avila et al. 2006), but the donors 
used were all neo-natal to pre-pubertal.  
 However, no studies delimited the precise window of donor ages that 
could be used for successful xenografting until our study using testes from 
domestic cats (Kim, Selvaraj et al. 2007). We found that the xenografts from 
pubertal cats failed to support post-meiotic germ cell development, despite 
producing normal amounts of bioactive testosterone. Our results also 
suggested a delay in sperm production, and some differences in the pattern of 
 175 
meiosis in the tubule cross-sections. Given these differences versus the 
success of xenografting in many other species, I next compared the nature of 
spermatogenesis in the xenografts from different species in carnivore. Unlike 
the delay in sperm production by the cat xenografts, the progression of germ 
cell development in the ferret testis xenografts was very similar to that in the 
intact animals. However, canine spermatogenesis was poorly supported to 
produce sperm in the xenografts compared to cat and ferret xenografts. In the 
rare instance when spermatogenesis was supported (<1% of pre-pubertal 
grafts yielded sperm), it did not show the same delay as in the cat. Although 
our study did not identify the factor that caused the different response in these 
three species, we were able to conclude that the success of testis xenografting 
was affected by species-specific factors rather than by an effect for all 
carnivores.  
 Despite the new approach to preserve male genetic information that 
testis xenografting represents, there are several key points of research that 
must be investigated before the technique becomes widely used. Namely, 
what underlies the difference between species? What causes the precipitous 
decline in success at the time of puberty? And most important, are the sperm 
of different species that are produced by xenografts functional?  
 
Lessons learned from studying spermatogonial stem cell transplantation 
 SSCT was introduced in 1994 using mice as donors and recipients 
(Brinster and Avarbock 1994). Although like testis xenografting, SSCT can be 
useful to preserve male genetic material from genetically valuable animals, 
this technology is limited in several ways. First, it is not simple to perform, 
requiring the isolation of germ cells from donor testes, the preparation of 
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recipients, and expertise in an effective method of retrograde injection. In 
addition, it requires a degree of taxonomic relatedness between the donor and 
recipient species for spermatogenesis to be supported. SSCT has been 
performed with various donor species including the goat (Honaramooz, 
Behboodi et al. 2003; Honaramooz, Megee et al. 2007), pig (Honaramooz, 
Megee et al. 2002), bull (Herrid, Vignarajan et al. 2006) or monkey (Schlatt, 
Foppiani et al. 2002). My studies expanded the number of species for which 
SSCT could be performed, including the development of an irradiation protocol 
to deplete endogenous male germ cells in the recipient cats (Kim, Selvaraj et 
al. 2006), and demonstration of successful SSCT in the dog, including donor 
cell isolation, recipient preparation, successful injection, and finally 
quantification of the relative yield of sperm of donor origin (Kim, Turner et al. 
2008). Successful canine SSCT suggests that this approach might be useful in 
attempts to develop transgenesis in dogs. 
 
Future directions 
 We demonstrated that feline testis xenografting could result in 
production of mature sperm. Because sperm produced in xenografts do not 
have outflow to the epididymis, they would eventually degenerate within the 
tubules of xenografts. We collected feline testis xenografts at different time 
points to determine the optimal time for harvesting sperm that would provide 
the best combination of viability and yield. Our results suggested that 45 
weeks after xenografting was optimal. We then tested their abilities to fertilize 
eggs through intracytoplasmic sperm injection (ICSI) and support normal 
embryo development.  We have not yet had success in generating normal 
blastocysts. For a next step, I propose that we test whether the sperm can 
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contribute to normal embryo development if they are co-injected with mature 
centrosomes collected from epididymal sperm. This approach has been shown 
to improve embryo production when feline testicular sperm were used for ICSI 
(Comizzoli, Wildt et al. 2006).  
 Although more than 70% of felid species and a high percentage of 
domestic cats show teratospemia (defined as ejaculation of <40% 
morphologically normal sperm), the cause(s) of this constellation of 
abnormalities remain unknown. Testis xenografting could be used to 
investigate teratospermia by comparing sperm production in a cat testis versus 
in the environment of a xenograft. If the problem were based within the germ 
cells, neither sample would produce normal sperm. However, if it was caused 
from an abnormal interaction with the neuroendocrine axis, sperm might be 
produced in the xenografts but not in the animal. This kind of approach could 
be complemented by genetic studies to determine whether there is an 
underlying genetic component to the abnormality. This study might provide 
insight into infertility in men, in addition to the cat. If a specific genetic defect 
were identified, one might then identify young males having the gene(s) and 
those with the normal gene profile, and perform SSCT to investigate the 
relative contributions of the germ cell versus the somatic cell compartments. 
 Unlike feline testis xenografts, canine spermatogenesis was rarely 
supported in xenograft. Therefore, the future study of dog testis xenografts 
should be focused on identifying the factor(s) causing the incompatibility 
between the canine tissue and the host murine system. As discussed earlier, 
canine FSH receptors should be the first candidate to study in this regard.  
 For SSCT in the rodent, the donor germ cells can be injected via the 
efferent ducts under a dissecting microscope (Brinster, Ryu et al. 2003; 
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Brinster and Zimmermann 1994; Parreira, Ogawa et al. 1998). Alternatively, 
ultrasonography has been used to guide the injection in the goats, pigs and 
bulls because the rete testis is hyperechoic, and the efferent ducts are buried 
within connective tissue between the tightly connected testis and epididymis, 
hindering direct injection in these species (Herrid, Vignarajan et al. 2006; 
Honaramooz, Behboodi et al. 2003; Honaramooz, Megee et al. 2002). 
However, neither of methods can be readily applied to cat testes because they 
are too tightly connected with the epididymis to utilize an efferent duct 
approach, and they are too small to apply an ultrasound probe and still 
manipulate the testis for injection into the rete. Therefore, I performed SSCT in 
the cat by injecting donor germ cells based on ratiometric landmarks without 
any visual guidance. However, the injection method was not appropriate to 
feed the cells into the rete testis and the seminiferous tubules, which resulted 
in our failure to obtain donor-derived sperm from all recipients. Although the 
morphology of cats has hindered the development of SSCT in this species, 
advancements in ultrasonography might overcome this obstacle [e.g. the 
Visualsonics Vevo 770 
(http://www.visualsonics.com/products/products_vevo770.htm), Visualsonics, 
Toronto, Ontario, Canada]. Because this machine can be used on small 
animals such as mice, it should be able to be used on cat testes to enable 
visual guidance of injections into the rete.  
  In addition to the potential for SSCT to be used for the preservation of 
male genetic information, SSCT can also be useful to study spermatogonial 
stem cells and to generate transgenic animals. Transgenic mice (Nagano, 
Brinster et al. 2001), transgenic rats (Honaramooz, Megee et al. 2008; Ryu, 
Orwig et al. 2007), and transgenic goats (Honaramooz, Megee et al. 2008) 
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have all been generated using this technique. Because transgenic dogs have 
never been generated due to the unavailability of canine ES cells and the 
difficulty of manipulating early embryos, SSCT should be considered strongly 
as an alternative approach to develop transgenesis in the dog. Even though 
lentiviral vectors are the most common transgene-carriers for mitotically 
quiescent stem cells, the development of other types of transfection such as 
nucleofection should also be considered because viral transduction requires 
maintaining cells in culture, during which time they might lose their stem cell 
characteristics. Our attempts to generate transgenic dogs using canine ES 
cells and blastocysts failed due to the instability of the putative ES cells and 
the lack of financial support to continue the projects. As a future direction, I 
would focus on utilizing our zona penetration methodology as a means of 
injecting both transduced cells as well as directly injecting viral vectors into 
blastocysts. This approach should be attempted until the ES cell lines that are 
currently available can be demonstrated to be stable after repeated passages.  
 Unlike other adult stem cells (not including induced pluripotent stem 
cells), SSC have the unique ability of germline transmission (Kanatsu-
Shinohara, Ogonuki et al. 2003), while also being able to transform into 
pluripotent stem cells under appropriate culture conditions (Kanatsu-
Shinohara, Inoue et al. 2004). In the future, canine SSC should be 
characterized in terms of their gene and protein profiles, and surface antigens.  
These could be different from those seen in murine SSC and could be used to 
enrich the cells and verify their “stemness” after being maintained in culture. 
Culturing canine SSC has not been successful in either our laboratory or that 
of a collaborator (pers. comm. Dr. Beverly Torok-Storb), making empirical 
development of this methodology another potentially useful topic of research.  
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